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ABSTRACT
Background: Cardiovascular disease and periodontitis are major global health problems that are a large 
burden for the individual and society. During the last 30 years, it has been discussed whether there is an 
association between the two diseases. One explanation of a possible association between these conditions 
is	 systemic	 low-grade	 inflammation	 derived	 from	 periodontitis	 or	 acute	 inflammation	 from	 invasive	
dental procedures and which initiates or accelerates the development of atherosclerosis. It has not yet 
been established whether the relation is causal or only an expression of shared risk factors.
Aims: To investigate the relation between oral health and cardiovascular disease by exploring the 
association between:
1. Periodontitis and myocardial infarction.
2. Periodontitis and myocardial infarction by gender.
3. Invasive dental treatment and incidence of myocardial infarction.
Association between periodontitis and a first myocardial infarction in the PAROKRANK study 
The PAROKRANK study, a prospective case-control study, recruited 805 cases and 805 controls from 17 
Swedish	hospitals.	Cases	were	patients	<75	years	with	a	first	myocardial	infarction,	which	were	examined	
including a dental examination and panorama radiograph 6 to 10 weeks after the index infarction. Disease 
and health-preserving risk variables were queried at the time of the examination. Similar investigations 
were	performed	in	controls	matched	for	age,	gender,	and	geographic	area.	Periodontitis	was	defined	by	
bone	loss:	healthy	(≥80%	remaining	bone),	mild-to-moderate	(79−66%),	or	severe	(<66%).	Moderate-to-
severe	periodontitis	was	more	common	in	cases	(43	vs.	33%,	p<0.001). Moderate-to-severe periodontitis 
significantly	increased	the	risk	of	a	first	myocardial	infarction	after	adjusting	for	diabetes,	smoking	habits,	
education	level,	and	marital	status	(OR	1.28;	95%	CI:	1.03−1.60).		In	785	cases	(19%	women)	and	792	
controls	(19%	women),	severe	periodontitis	increased	the	risk	of	a	first	myocardial	infarction	in	women	
(adjusted	OR	3.72;	95%	CI:	1.24−11.16),	especially	below	age	65	years	 (adjusted	OR	5.26;	95%	CI:	
1.03−26.76).
Association between periodontitis and a first myocardial infarction in a nation-wide setting
Merging	data	from	The	National	Board	of	Health	and	Welfare	with	data	from	Statistics	Sweden	identified	
cases	(n=51,884)	with	a	first	myocardial	infarction	(ICD	10	code	I.21)	and	controls	(n=246,978)	during	
2011-2013. Controls were matched 5:1 by age, gender and geographic area and free from prior myocardial 
infarction. Periodontal treatment derived from The Dental Health Register three years before the index 
date was used as a surrogate marker for periodontitis: (i) No record of dental treatment, (ii) No record 
of periodontal treatment, (iii) One or more non-advanced periodontal treatments, or (iv) One or more 
advanced periodontal treatments. No association between advanced periodontal treatment and incident 
myocardial	infarction	was	found	after	adjustments	(OR	1.02;	95%	CI:	1.00−1.05), or in subjects with a 
high	yearly	frequency	of	advanced	periodontal	treatment,	including	periodontal	surgery	(OR	1.14;	95%	
CI: 1.00−1.29).
Association between invasive dental treatment and a first myocardial infarction
In the nation-wide case-control study population, the association between invasive dental treatment 
(defined	by	procedure	 and	 codes	 for	 sub-gingival	 curettage,	 dento-alveolar	 surgery,	 tooth	 extractions,	
implant	surgery,	apical	surgery	or	periodontal	surgery)	and	a	first	myocardial	 infarction	(ICD	10	code	
I.21)	within	4	weeks	was	investigated.	Invasive	dental	treatment	before	a	first	myocardial	infarction	was	
not	associated	with	an	increased	risk	of	a	myocardial	infarction	(adjusted	OR	0.98;	95%	CI:	0.91−1.06).  
Conclusions: In nationwide contemporary populations periodontitis slightly increased the risk for 
experiencing	a	first	myocardial	infarction	with	even	stronger	risks	in	women,	particular	in	those	65	years	
or younger. However, when using periodontal treatment as a surrogate marker for periodontitis there was 
no	evidence	 that	an	association	 to	a	first	myocardial	 infarction	was	of	any	significance	 in	 the	general	
Swedish population. Invasive dental treatment, including dental surgery and tooth extractions, was not 
associated	with	an	increased	risk	of	a	first	myocardial	infarction.	
Eva Nordendahl
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SAMMANFATTNING
Bakgrund: Hjärt-kärlsjukdom och parodontit är stora globala folksjukdomar som orsakar mycket lidande 
och som leder till stora hälsoproblem. Under de senaste 30 åren har ett eventuellt samband mellan dessa 
två	 tillstånd	 diskuterats.	 Som	 en	 förklaringsmodell	 har	 inflammation	 föreslagits,	 genom	 att	 låggradig	
systemisk	 inflammation	orsakad	 av	parodontit	 eller	 akut	 inflammation	 från	 invasiva	 tandingrepp,	 kan	
påverkar progressionen av ateroskleros. 
Det råder dock fortfarande delade meningar om det föreligger ett direkt orsakssamband mellan dessa två 
tillstånd eller om det bara beror på gemensamma riskfaktorer.
Målsättning: Att undersöka om oral hälsa utgör en riskfaktor för utvecklingen av hjärt-kärlsjukdom, 
framförallt sambandet mellan parodontit, invasiva tandingrepp och hjärtinfarkt.
1. Studera sambandet mellan parodontit och hjärtinfarkt
2. Studera sambandet mellan parodontit och hjärtinfarkt ur ett könsperspektiv
3. Studera sambandet mellan invasiva tandingrepp och risken för en hjärtinfarkt
Sambandet mellan parodontit och hjärtinfarkt, PAROKRANK studien
Sambandet mellan parodontit och hjärtinfarkt undersöktes i en prospektiv fall-kontroll studie inkluderande 
805 patienter (fall) 75 år eller yngre med en första händelse av hjärtinfarkt vid någon av 17 deltagande 
sjukhus runt om i Sverige. Kontroller var personer som matchades på ålder, kön och bostadsort samt 
var fria från tidigare hjärtinfarkt. Samtliga deltagare genomgick medicinsk- och tandundersökning 
inkluderande	 röntgen.	 Parodontit	 klassificerades	 i	 tre	 grupper	 utifrån	 alveolär	 benhöjd:	 Frisk	 (≥80%	
kvarvarande	ben),	mild/moderat	(79-66%)	eller	grav	(<66%).	Mild/moderat	eller	grav	parodontit	var	mer	
förekommande	hos	fallen	(43	mot	33	%,	p<0.001).	Moderat	till	grav	parodontit	var	signifikant	associerat	
med hjärtinfarkt, efter hänsyn tagen till andra viktiga faktorer; diabetes, rökning, utbildning och civilstånd, 
OR	1.28;	95%	CI:	1.03-1.60.	Hos	785	fall	(19%	kvinnor),	och	792	kontroller	(19%	kvinnor),	var	grav	
parodontit	signifikant	associerad	till	hjärtinfarkt,		(justerat	OR	3.72;	95%	CI:	1.24-11.16),	framför	allt	i	
åldersgruppen	65	år	eller	yngre	(justerat	OR	5.26;	95%	CI:	1.03-26.76).
Sambandet mellan parodontit och hjärtinfarkt i en nationell registerbaserad fall-kontroll studie 
Data från Socialstyrelsen samt från Statistiska Centralbyrån inhämtades mellan 2011-2013 och 
resulterade i 51 884 fall med en förstagångs hjärtinfarktdiagnos (ICD 10 kod I.21) och 246 978 kontroller 
som	var	matchade	5:1	för	ålder,	kön	och	geografisk	bostadsort.	Exklusionskriterium för kontroller var 
tidigare hjärtinfarkt. För exponeringen parodontit användes parodontal behandling som ett surrogat 
mått för parodontit. Information om tandvårdsåtgärder hämtades från Tandhälsoregistret (3 år innan 
infarkttillfället).	 Information	gällande	parodontala	behandlingar	klassificerades	 i	 fyra	olika	grupper:	 i) 
Ingen registrerad tandvård, ii) Ingen registrerad parodontal vård, iii)	En	eller	fler	utförda	lätta	parodontala	
behandlingar eller iv)	En	eller	fler	utförda	avancerade	parodontala	behandlingar.	Resultaten	visade	inget	
samband mellan avancerad parodontal behandling och hjärtinfarkt, efter att hänsyn tagits till relevanta 
faktorer;	diabetes,	inkomst	och	utbildningsgrad	(OR	1.02;	95%	CI:	1.00-1.05),	inte	heller	för	individer	
som	utförde	3	eller	fler	avancerade	parodontal	behandlingar,	i	kombination	med	parodontal	kirurgi	(OR	
1.14;	95%	CI:	1.00−1.29).
I samma studiepopulation undersöktes sambandet mellan invasiva tandingrepp och hjärtinfarkt. Inget 
samband mellan invasiva tandåtgärder och risken för en förstagångs hjärtinfarkt kunde påvisas efter 
justering av relevanta faktorer; tidigare hjärt-kärlsjukdom, hjärt-kärl läkemedel, diabetes, inkomst och 
utbildningsgrad	(OR	0.98;	95%	CI:	0.91-1.06).
Sammanfattning: I en modern population, är parodontit vanligare hos patienter som har överlevt en 
förstagångs hjärtinfarkt i jämförelse med friska kontroller. Grav parodontit verkar vara en starkare 
riskfaktor för hjärtinfarkt hos kvinnor i jämförelse med män, framförallt hos kvinnor 65 år eller yngre. 
Resultat från ett nationellt material visar dock ingen förhöjd risk för hjärtinfarkt hos individer med 
parodontit, när man använder parodontal behandling som en markör för parodontit. Invasiva tandingrepp, 
inkluderande operationer och extraktioner, är inte förenade med en förhöjd risk för hjärtinfarkt i en svensk 
befolkning. 
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INTRODUCTION
During the last century, the effects of oral 
infections on systemic health have been a much 
discussed topic.1 Dr. Willoughby D. Miller 
suggested that oral infections could cause different 
diseases. This started “the focal infection theory”, 
which was accepted by general medicine in the 
1920s.2 The main principle of the theory was that 
oral microorganisms and the metabolic products 
produced by the ensuing local infections entered 
the bloodstream and caused systemic disorders. 
This resulted in extreme dental treatments, such as 
therapeutic edentulation, where otherwise healthy 
teeth were extracted to prevent the occurrence of 
systemic diseases.3 Over time, clinicians began to 
question this radical form of treatment, especially 
as patients who underwent total tooth extraction 
reaped	no	apparent	health	benefits	compared	with	
those who had not had such invasive treatment, 
rather the opposite occurred. By the 1940s, researchers had discredited the focal infection 
theory, and the discussion slowly faded thereafter.4
In the late 1980s, an association between oral infections and cardiovascular disease gained 
renewed attention and the theory re-emerged.5,6	Numerous	 publications	 in	 this	 field	 have	
since	suggested	an	inflammatory	link	between	the	two	conditions.	Inflammation	is	the	human	
body’s natural defense and an essential process that protects us from our environment. Aulus 
Cornelius	Celsus	(c.	25	BC	–	c.	AD	50)	was	one	of	 the	first	 to	describe	 the	four	cardinal	
signs	of	inflammation:	redness	(rubor), warmth (calor), swelling (tumor), and pain (dolor).7 
This defense helps the body resist bacterial invasion in damaged tissue and initiate a healing 
process. If the infection could not be resolved, it would, with high probability, become a 
chronic	pathological	condition	with	persistent	inflammation	and	tissue	destruction.	
Although a potential causal relationship has been suggested between oral infection and 
cardiovascular	disease	with	inflammation	as	the	link,	and	many	studies	have	reported	positive	
associations,	there	are	still	knowledge	gaps	in	the	field.	
PERIODONTAL DISEASE 
Periodontal	disease	is	an	inflammatory	condition	and	a	major	global	public	health	problem	
that	 affects	 the	majority	 of	most	 populations	 after	 the	 age	 of	 35−40	years.8,9 The disease 
includes both a reversible and an irreversible condition. Gingivitis, the reversible form, 
involves	 inflammation	of	 the	gingival	 tissue	and	 the	 irreversible,	periodontitis,	affects	 the	
supporting tissue of the teeth.10 Figure 2 illustrates the periodontium and the development of 
periodontitis.
Figure 1. Dr. Willoughby D. Miller
Eva Nordendahl
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GINGIVITIS
Gingivitis	 is	a	 reversible	 inflammation	of	 the	gingival	 tissue,	usually	 initiated	by	bacteria	
from dental plaque; but nonplaque-induced gingivitis, such as allergies and viral infections 
are also known.9 A clinical examination will identify gingivitis, which comprises redness, 
swelling, and bleeding of the gingival tissue. Optimizing oral hygiene can reverse the 
condition.11	Gingivitis	affects	50−90%	of	the	adult	population	worldwide.12 Data on 50-year-
olds	in	Sweden	show	that	gingivitis	decreased	from	38%	in	1973	to	15%	in	2013	(Figure	3).13 
Figure 2. Schematic illustration of the periodontium and the development of periodontitis.
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Figure 3. Distribution of all individuals 20–70 years according to periodontal health and periodontal 
disease experience in Jönköping County, Sweden 1973–2013. Reprinted with permission from 
Norderyd O et al., Swedish Dental Journal, 2015;39:69-86.13
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PERIODONTITIS
Periodontitis is characterized by loss of attachment and alveolar bone and the formation 
of periodontal pockets.9,10 Periodontitis is diagnosed by clinical and/or radiographic 
examinations.	The	most	 important	parameters	 for	 the	diagnosis	 are	pocket	depth	≥4	mm,	
bleeding on probing of the dental pocket, clinical and radiographic signs of attachment 
loss, amount of dental plaque, furcation-involved teeth, and tooth mobility.11 Different 
classifications	 of	 periodontitis	 have	been	 suggested	 over	 the	 years	 (Table	 1).	The	 current	
classification	is	based	on	the	2017	World	Workshop	on	the	Classification	of	Periodontal	and	
Peri- implant Diseases and Conditions.14 
Table 1.  International consensus criteria for the classification of periodontitis.
Classification according to Case definition
Armitage 199915
“Development of a 
Classification System
for Periodontal Diseases 
and Conditions”
Extent
Localized ≤ 30% of the sites affected
Generalized > 30% of the sites affected
Severity
Slight 1 – 2 mm CAL
Moderate 3 – 4 mm CAL
Severe ≥ 5 mm CAL
Page and Eke 200716 
“Case Definitions for 
Use in Population 
Based Surveillance of                   
Periodontitis”
No/mild 
periodontitis
Not fulfilling criteria for 
moderate or severe disease
Moderate 
periodontitis
≥ 2 interproximal sites with CAL ≥ 4 mm (not 
on the same tooth) or ≥ 2 interproximal sites 
with PPD ≥ 4 mm (not on the same tooth)
Severe 
periodontitis 
≥ 2 interproximal sites with CAL ≥ 6 mm (not 
on the same tooth)
and ≥ 1 interproximal sites with PPD ≥ 5 mm 
(not on the same tooth)
Disease Severity and Complexity of Management
Papapanou et al. 201814
“Periodontitis: 
Consensus report of 
workgroup 2 of the 
2017 World Workshop 
on the Classification 
of Periodontal and 
PeriImplant Diseases 
and Conditions”
Stage I:  Initial 
periodontitis
Stage II: 
Moderate 
periodontitis
Stage III:
Severe 
periodontitis 
with potential 
for additional 
tooth loss
Stage IV: 
Advanced 
periodontitis 
with extensive 
tooth loss and 
potential for loss 
of dentition
Evidence or risk of rapid 
progression, anticipated 
treatment response, 
and eﬀects on systemic 
health
Grade A
Grade B
Grade C
Stage (Table 2) 
Grade (Table 3) 
CAL = clinical attachment level, PPD = periodontal pocket depth
Eva Nordendahl
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The	new	classification	system	adds	a	multi-dimensional	perspective	and	includes	both	current	
status (stage; Table 2) and the risk of disease progression (grade; Tables 3).14 
Table 2. Periodontitis stage according to the 2017 World Workshop on the Classification of Periodontal 
and Peri-implant Diseases and Conditions.14 
Periodontitis stage
I II III IV
Severity Interdental 
CAL at site of 
greatest loss
1 to 2 mm 3 to 4 mm ≥ 5 mm ≥ 5 mm
Radiographic 
bone loss
Coronal third 
(<15%)
Coronal third 
(15% to 33%)
Extending to mid-
third of root and 
beyond
Extending to mid-third of 
root and beyond
Tooth loss No tooth loss due to periodontitis Tooth loss due to peri-
odontitis of ≤ 4 teeth
Tooth loss due to 
periodontitis of  ≥ 5 teeth
Complexity Local Maximum probing 
depth ≤ 4 mm. 
Mostly horizontal 
bone loss
Maximum 
probing depth 
≤ 5 mm. 
Mostly 
horizontal bone 
loss
In addition to stage II 
complexity :
Probing depth            
≥ 6 mm. 
Vertical bone loss ≥ 3 
mm. 
Furcation 
involvement Class II 
or III.
Moderate ridge 
defect.
In addition to stage III 
complexity: 
Need for complex 
rehabilitation due to: 
Masticatory dysfunction. 
Secondary occlusal 
trauma (tooth mobility 
degree ≥ 2).
Severe ridge defect, Bite 
collapse, drifting, ﬂaring.
Less than 20 remaining 
teeth (10 opposing pairs).
Extent and 
distribution
Add to stage 
as descriptor
For each stage, describe extent as localized (<30% of teeth involved), generalized, or 
molar/incisor pattern
CAL = clinical attachment level
Table 3. Periodontitis grade according to the 2017 World Workshop on the Classification of Periodontal 
and Peri-implant Diseases and Conditions.14 
Periodontitis grade
A
Slow rate of 
progression
B
Moderate rate 
of progression
C
Rapid rate of progression
Primary 
criteria
Direct evidence 
of progression
Longitudinal data 
(radiographic 
bone loss or CAL)
Evidence of no 
loss over 5 years
< 2 mm over 5 
years
≥ 2 mm over 5 years
% bone loss/age < 0.25 0.25 to 1.0 > 1.0
Indirect 
evidence of 
progression
Case phenotype Heavy biofilm 
deposits with 
low levels of 
destruction
Destruction 
commensurate 
with biofilm 
deposits
Destruction exceeds 
expectation given biofilm 
deposits; specific clinical 
patterns suggestive of periods 
of rapid progression and/
or early onset disease (e.g., 
molar/incisor pattern; lack of 
expected response to standard 
bacterial control therapies) 
Grade 
modifiers
Risk factors
Smoking Non-smoking Smoker < 10 
cigarettes/day
Smoker ≥ 10                         
cigarettes/day
Diabetes
Normoglycemic/
no diagnosis of 
diabetes
HbA1c < 7.0% 
in patients with 
diabetes
HbA1c ≥ 7.0% in patients 
with diabetes
Risk of 
systemic 
impact of 
periodontitis
Inﬂammatory 
burden hsCRP < 1 mg/L 1 to 3 mg/L > 3 mg/L
Biomarkers Indicators of CAL/bone loss
Saliva, gingival 
crevicular ﬂuid, 
serum
CAL = Clinical attachment level, HbA1c = Hemoglobin A1c, hsCRP = High sensitivity CRP
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One	 of	 several	 reasons	 for	 changing	 the	 classification	 of	 periodontitis	 was	 the	 difficulty	
of estimating the extent of periodontal destruction in epidemiological studies. The new 
classification	system	provides	a	more	detailed	understanding	of	the	periodontal	destruction	
and is more suitable for epidemiological research. In this thesis, prevalence data on 
periodontitis are based on the 1999 International Consensus Report on Periodontitis15 and 
case	definitions:	the	Centers	for	Disease	Control	and	Prevention	and	the	American	Academy	
of Periodontology16 and the Community Periodontal Index of Treatment Needs.17 
The prevalence of periodontitis has been estimated at 30−50%	 but	 varies	 considerably	
between populations.9	The	 advanced	 form,	 severe	 periodontitis	with	 a	 high	 inflammatory	
host-response, is less prevalent and has been estimated at 9−11%.18,19 In Sweden, prevalence 
has	decreased	from	13%	in	1983	to	9%	in	2013	(Figure	3).13
The pathogenesis of periodontitis 
Periodontitis	 is	 a	 microbially	 induced,	 tissue	 degrading,	 non-resolving	 inflammation.	 It	
primarily	affects	the	collagen	fibers	that	attach	the	tooth	to	the	alveolar	bone	and	secondly	
the	bone	 itself.	A	pathogenic	biofilm	 is	a	 required	precondition	 for	development,	but	 it	 is	
insufficient	to	cause	disease.20 Periodontitis results from an imbalance between a pathogenic 
biofilm	and	the	inflammatory	response	of	the	host,	where	the	inflammatory	immune	response	
has a central role (Figure 4).21
Periodontitis	 is	 influenced	by	multiple	risk	factors:	some,	such	as	behavioral	factors	(e.g.,	
smoking)	are	modifiable;	others	(e.g.,	diabetes)	are	intrinsic;	and	some	are	genetic.9,22,23 Site-
specific	factors,	such	as	anatomical	differences,	may	also	favor	disease	development.	
Interactions	between	the	local	inflammatory	response	and	bacterial	plaque	can	induce	changes	
in	the	biofilm	that	favor	bacterial	species,	which	in	susceptible	individuals	accumulate	and	
make	 the	 biofilm	 more	 pathogenic.20,21 This heightens the host response, which may lead 
to	 gingival	 inflammation,	 gingivitis.	 The	 biofilm	 becomes	 incipient	 dysbiotic,	 and	 in	 non-
susceptible	individuals,	the	disease	develops	no	further	than	gingival	inflammation.	
However,	if	the	individual	is	susceptible	to	periodontitis,	the	incipient	dysbiotic	biofilm	activates	
a	disproportional	host	response,	increasing	the	release	of	proinflammatory	cytokines,	reactive	
oxygen species, and tissue-degrading proteases. Periodontal tissue degradation and chronic 
inflammation	then	result.	This	chronic	inflammatory	state	is	characterized	by	efforts	to	heal,	
(angiogenesis	and	fibrosis),	all	the	while	inflammation	is	actively	sustaining	dysbiosis	in	the	
pathogenic	biofilm.	If	the	biofilm	is	not	disrupted	or	removed,	frank	dysbiosis	will	perpetuate	
chronic	 (non-resolving),	destructive	 inflammation.	To	 resolve	 this	progressing	periodontitis,	
the	biofilm	must	be	eliminated	though	intervention,	so	that	health-promoting	microbial	species	
can	be	re-established	and	initiate	a	reduction	in	inflammation.21
CARDIOVASCULAR DISEASE 
Cardiovascular disease, a common term for heart and vascular disorders related to atherosclerosis, 
is a major global health problem.24 Globally, cardiovascular disease is the leading cause of 
death; it is decreasing in the Western world but on the rise in developing countries.25
Eva Nordendahl
16
Fi
gu
re
 4
. S
ch
em
ati
c 
ill
us
tr
ati
on
 o
f h
os
t-
m
ic
ro
be
 in
te
ra
cti
on
s 
in
 t
he
 p
at
ho
ge
ne
si
s 
of
 p
er
io
do
nti
ti
s,
 in
 w
hi
ch
 t
he
 h
os
t 
re
sp
on
se
 d
ri
ve
s 
an
 in
ci
pi
en
t 
dy
sb
io
si
s 
(g
in
gi
vi
ti
s)
. I
f t
he
 b
io
fil
m
 is
 n
ot
 d
is
ru
pt
ed
/r
em
ov
ed
, f
ra
nk
 d
ys
bi
os
is
 r
es
ul
ts
 a
nd
 p
er
pe
tu
at
es
 c
hr
on
ic
 (n
on
-r
es
ol
vi
ng
) d
es
tr
uc
ti
ve
 in
ﬂa
m
m
ati
on
. R
ep
ro
du
ce
d 
w
it
h 
pe
rm
is
si
on
 fr
om
 M
ey
le
 a
nd
 C
ha
pp
le
, P
er
io
do
nt
ol
 2
00
0.
 2
01
5;
69
(1
):
7-
17
.21
          Oral Health and Myocardial Infarction
17
In 2015, an estimated 423 million people worldwide suffered from cardiovascular disease; 18 
million died from the disease, with 7.3 million deaths due to myocardial infarction.24 In Europe, 
2.2	million	women	and	1.8	million	men	died	from	cardiovascular	disease,	accounting	for	49%	
and	40%	of	all	deaths	in	women	and	men.26 Men, however, are more often affected earlier in 
life compared to women. Myocardial infarction is responsible for the majority of deaths due to 
cardiovascular disease.24  In 2017, approximately 26,000 individuals suffered from a myocardial 
infarction	in	Sweden;	15%	were	fatal	within	the	first	28	days,	and	4%	were	below	the	age	of	
50 years.27  Figure 5 illustrates the trends in myocardial infarction incidence and mortality 
in	 Sweden	 during	 2002−2017,	 dichotomized	 for	 women	 and	 men.	As	 the	 INTERHEART	
study describes, risk factors for myocardial infarction are similar around the world.28 Based on 
29,972	cases	and	controls	from	52	countries,	it	was	shown	that	nine	modifiable	factors	could	
explain	90%	of	all	myocardial	infarction	in	men	and	women.	Six	were	risk	factors	(smoking,	
hypertension, elevated apolipoprotein B, abdominal obesity, psychosocial stress, and diabetes) 
and three were protective factors (physical activity, moderate consumption of alcohol, and high 
proportions of vegetables and fruit intake). 
The pathogenesis of atherosclerosis
Atherosclerosis begins early in life but progresses slowly, thus clinical symptoms are rare before 
40	years	of	age.	Though	it	has	been	well	established	that	inflammation	plays	a	central	role	in	
the pathophysiology of the disease, the underlying biological mechanisms of its development 
are	still	not	fully	clarified.29,30
During early development of atherosclerotic plaque, various factors activate the endothelial cells 
of the vessel wall; one of these factors is low-density lipoprotein (LDL).31 LDL particles attach 
to glucosaminoglycans in the intima region of the vessel wall and become oxidized. Oxidized 
LDL activates the endothelium, whereby molecules are secreted and adhesion molecules 
expressed. As a result, monocytes and T-lymphocytes, which normally resist attachment to 
arterial endothelial cells, are attracted and attach to the vessel wall.29 Once the monocytes 
have entered the artery wall, they differentiate into tissue macrophages and begin to express 
scavenger receptors, which attach to the oxidized LDL. Macrophages transform into lipid foam 
Figure 5. Incidence and number of deaths due to myocardial infarction in Sweden 2002-2017, 
dichotomized for women and men. Adapted with permission from The Swedish National Board of 
Health and Welfare.27 
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cells	by	absorbing	modified	lipoproteins,	leading	to	fatty-streak	formation	in	the	vessel	intima	
and further development of the plaque. In the center of the atherosclerotic plaque, a core region 
is formed by an increase of foam cells and extracellular lipids. The atherosclerotic plaque is 
surrounded	by	smooth	muscles,	including	collagen	and	elastin,	forming	a	fibrous	cap,	which	
covers the plaque. Some foam and smooth muscle cells in the plaque die through apoptosis and 
release lipids that accumulate in the central region of the plaque, which together with cellular 
debris form a lipid-rich core, called the necrotic core.30 The atherosclerotic plaque causes the 
inner	 surface	of	 the	arteries	 to	be	 irregular	 and	 the	 lumen,	narrow,	which	 restricts	 the	flow	
of blood and eventually causes tissue ischemia and other clinical manifestations.29-34 In time, 
areas of the plaque can rupture, and a blood clot forms. If this occurs in the coronary artery, 
the result can be a myocardial infarction. Figure 6 is a schematic picture of the pathogenesis of 
atherosclerosis, showing the stages from plaque formation to plaque rupture. 
Myocardial infarction
The most common mechanism of a myocardial infarction is atherosclerotic plaque rupture in 
the coronary artery, resulting in thrombosis and occlusion of the coronary artery. Blood supply 
is reduced with ensuing ischemia in the myocardium and possibly necrosis.35	A	confirmed	
1 2
43
Endothelial 
permeability
Leukocyte 
migration
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adhesion
Leukocyte 
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Media
Adventitia
Macrophage 
accumulation
Formation of 
necrotic core
Fibrous-cap 
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Plaque rupture Thinning of 
fibrous cap
Hemorrhage from 
plaque microvessels
Smooth-
muscle 
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aggregation of 
platelets
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and entry of 
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Figure 6. The pathogenesis of atherosclerosis: (1) Endothelial dysfunction, (2) Fatty-streak formation, 
(3) Formation of an advanced lesion, and (4) Unstable fibrous plaque. Reproduced with permission 
from Ross, R. N Engl J Med 1999;340(2):115-26, Copyright Massachusetts Medical Society.30 
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myocardial infarction includes one of the following criteria: characteristic electrocardiogram 
changes,	 elevated	cardiac	 troponin	values	or	 an	autopsy-confirmed	myocardial infarction, 
according to joint recommendations from the European Society of Cardiology and the 
American College of Cardiology in 2000 and 2018, with slight adjustments during the 
years.35,36
An acute myocardial infarction has one of two clinical presentations: an ST-segment elevation 
myocardial infarction (STEMI) or a non-ST-segment elevation myocardial infarction 
(NSTEMI). STEMI is caused by more severe ischemia due to acute occlusion of a major 
coronary artery and will require rapid reperfusion.35 
Today,	 there	 are	five	 types	of	 	myocardial	 infarction,	based	on	pathological,	 clinical,	 and	
prognostic factors. Treatment strategies for the different types varies. Type 1 is the most 
common form. A type-1 myocardial infarction is designated as an atherothrombotic coronary 
artery disease, which is usually caused by atherosclerotic plaque disruption (Figure 7). Typi-
cal symptoms include central chest pain or discomfort. Symptoms of a myocardial infarction 
may, however, differ between men and women. Atypical symptoms occasionally predominate 
and are suggested to be more common in women. These include shortness of breath; pain in 
the	upper	back,	jaw,	or	neck;	flu-like	symptoms;	fatigue	or	weakness;	feelings	of	anxiety;	or	
loss of appetite.37 Myocardial infarction that is precipitated by an ischemic myocardial injury, 
due	to	a	discrepancy	between	oxygen	supply	and	demand,	is	classified	as	a	type-2	myocardial	
infarction (Figure 7). When detected at autopsy, cardiac death before biomarker sampling is 
classified	as	a	type-3	myocardial	infarction.	Type-4	myocardial	infarctions	develop	in	situ-
ations related to percutaneous coronary intervention (PCI) or stent complications. Type-5 
myocardial infarctions are associated with coronary artery bypass grafting.35 Acute treatment 
for myocardial infarction is PCI with stent implantation or if unavailable, thrombolysis. 
Type 1 Type 2
Figure 7. Development of type-1 and type-2 myocardial infarction. Adapted with permission from 
Thygesen et al., Eur Heart J. 2019;40:237-69.35
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ASSOCIATION BETWEEN PERIODONTAL AND CARDIOVASCULAR 
DISEASE 
In 1989, Mattila et al. drew new interest to the area when they demonstrated a clear 
association between myocardial infarction and dental infections.5 Since then, numerous of 
epidemiological studies − cross-sectional,38-46 case-control5,47-63 and cohort studies6,64-68 − 
have reported positive associations between periodontitis and cardiovascular disease. Due 
to	the	varying	definitions	of	periodontitis	used,	results	have	been	difficult	to	compare.	For	
instance,	periodontitis	could	be	reported	as	clinical	findings	from	a	partial-mouth	or	a	full	
mouth examination, and be measured differently (i.e. attachment loss, pocket depth, tooth 
loss, or radiographically measured bone loss). Other methodological considerations are 
varying	sizes	of	study	population,	different	classifications	systems	of	periodontitis,	historical	
controls, only retrospective data, self-reported exposures or outcomes, and inaccurate clinical 
examination techniques.
Table 4 presents a selection of positive and negative publications based on relatively large 
study populations. Some of these, however, lack matched controls, some lack information on 
confounders, and some only include men. Study results diverge; some studies found positive 
associations between periodontitis and cardiovascular disease that varied from 1.1 to an 
extreme 14.1 while others found no association. Two meta-analyses,69,70 based on several 
of the studies in Table 4,39,42,43,51,60,64,71-74 found an association between periodontitis and 
cardiovascular disease where the pooled odds ratio (OR) for cross-sectional and case-control 
studies varied from 2.22 to 2.35 and relative risk (RR) for cohort studies from 1.14 to 1.34.
In 2012, the American Heart Association concluded that epidemiological studies have 
demonstrated a correlation between periodontitis and cardiovascular disease, but evidence 
of a causal relation is lacking.83 In this context, it is important to remember that a positive 
association, due to biological mechanisms or simply by shared confounding risk factors, 
differs from causality (Figure 8). Moreover, despite positive associations, the evidence that 
periodontal interventions prevent cardiovascular disease has been inconclusive.84 
Periodontitis Cardiovascular disease 
Periodontitis Cardiovascular disease 
Unmeasured confounders 
Confounders
A
B
Periodontitis Cardiovascular disease 
Unmeasured confounders 
Confounders
Mediators C
Figure 8. Schematic illustration of a potential causal pathway between periodontitis and 
cardiovascular disease. (A) A true causal relationship between periodontitis and cardiovascular 
disease. (B) An association between periodontitis and cardiovascular disease due to an extraneous 
factor. (C) An association between periodontitis and cardiovascular disease due to a modifying and 
an extraneous factor. Nordendahl 2019 (unpublished)
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POSSIBLE EXPLANATIONS FOR AN ASSOCIATION BETWEEN 
PERIODONTITIS AND CARDIOVASCULAR DISEASE
Some well-established risk factors for cardiovascular disease are also risk factors for the 
development of periodontitis and are described below. 
Smoking 
The harmful effects and prognostic implications of smoking on periodontitis and 
cardiovascular disease are well documented, and smoking is likely the strongest risk factor 
for both diseases.23,28,85-88 
The biological effects of smoking on the oral environment are not fully understood. However, 
it	 is	 established	 that	 smoking	 affects	 inflammatory	 and	 immunological	 responses	 and	 the	
healing potential of periodontal connective tissue.89
A 10-year prospective study reported a lower level of periodontal health in smokers compared 
to non-smokers.85 Studies have consistently shown both higher prevalence and greater 
severity of periodontitis in smokers compared to non-smokers.86,90,91 A recent meta-analysis 
has	further	highlighted	the	increased	risk	of	periodontitis	in	smokers	−	an	85%	higher	risk.92
The INTERHEART study concluded that smoking is the one, most important factor in 
the development of myocardial infarction globally.28 They reported a resilient and graded 
relation between number of smoked cigarettes and risk of myocardial infarction. Reducing or 
quitting smoking could lower the risk of a myocardial infarction by as much as, or more than, 
three-quarters.93	In	men,	smoking	was	associated	with	a	43%	risk	of	myocardial	infarction	
compared	with	15%	 in	women;	however,	 smoking	has	also	been	documented	 to	be	more	
harmful in women than men aged 65 years and under.28,94 
Diabetes mellitus 
Diabetes mellitus (diabetes) is a well-established risk factor for both periodontitis and 
cardiovascular disease. The incidence of diabetes is higher in patients with periodontitis and 
patients with diabetes appear to have more severe periodontitis.95-98 
Diabetes is a metabolic disorder caused by reduced insulin secretion and/or reduced 
insulin sensitivity, resulting in hyperglycemia. The disease is associated with macro- and 
microvascular complications, which compromises wound healing. In the oral cavity, high 
glucose levels potentially impact the microbiota, reduce defenses, and make wound healing 
difficult,	increasing	the	risk	of	deeper	pockets	and	more	severe	periodontitis.99,100 Additionally, 
periodontal	 inflammation	increases	levels	of	systemic	proinflammatory	biomarkers,	which	
aggravates insulin resistance.95,96 
Due to impaired vascular circulation and accelerated macro- and microangiopathy, diabetes 
is an important risk factor for cardiovascular disease.101,102 Diabetes has been associated with 
a	2−4-fold	higher	risk	of	myocardial	infarction,28,103,104 and a worse outcome of myocardial 
infarction, especially in women younger than 65 years.105-107
Socioeconomic status
It has been suggested that low education and low socioeconomic status are related to the 
development of periodontitis.108-111 However, whether the socioeconomic status itself 
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increases the risk or if it is only a risk indicator is uncertain. A systematic review on 
socioeconomic status, including income, occupation, education, unemployment, social 
class, living conditions, and race, reported that if the results were adjusted for smoking, the 
increased risk of periodontitis disappeared.112 This indicates that this risk factor is more of an 
risk indicator. In contrast, a Swedish cross-sectional study reported an association between 
low socioeconomic standards and oral health. The economic situation was worse in patients 
with severe periodontitis and a third of the patients had avoided dental care in the last year.111
Socioeconomic	 factors	 influence	 the	 risk	 of	 developing	 cardiovascular	 disease.113 Data 
from the Women’s Health Study shows that the RR of incident cardiovascular disease 
events decreased with increasing education and income.114 One possible explanation is that 
individuals with low socioeconomic status have lifestyles that include lower use of health 
care, chronic stress, and environmental and behavioral issues. In addition, the prognosis after 
myocardial infarction is worse for those with lower socioeconomic status.115
Gender
The prevalence of periodontitis has been reported to be more common in men compared 
to women.23,116	Gingival	inflammation	and	bleeding,	as	well	as	higher	levels	of	plaque	and	
calculus, have been more frequently reported in men. However, attitude and lack of good oral 
health behavior have been suggested to be the likely explanation for this difference.23 A meta-
analysis of gender differences for periodontitis found that men seem to be at a higher risk 
of developing the disease. However, men seem to have the same risk as women for severe 
destruction of the periodontium.117 
Women	suffer	from	their	first	myocardial	infarction	approximately	10	years	later	in	life	than	
men with increasing incidence after menopause.88,94 Several pathophysiological explanations 
have been proposed, and the protection of estrogen is regarded as a major component.118 
Other	factors	after	menopause	are	adverse	lipid	profile	and	hypertension.94,119 Despite this, 
some women experience a myocardial infarction before menopause; the mechanisms for this 
are not completely understood.106 
SUGGESTED MECHANISMS OF THE POTENTIAL CAUSAL 
RELATIONSHIP BETWEEN PERIODONTITIS AND CARDIOVASCULAR 
DISEASE 
Several pathophysiological mechanisms between periodontitis and cardiovascular disease 
have been suggested.120 The two pathways that dominate the discussion are described below: 
(1)	An	indirect	link	whereby	the	actions	of	periodontal	bacteria	induce	local	inflammation,	
which	 leaks	 proinflammatory	 mediators	 into	 the	 systemic	 circulation	 and	 gives	 rise	 to	
systemic	 inflammation,	 and	 (2)	A	 direct	 link	 whereby	 periodontal	 bacteria	 and	 bacterial	
products spread throughout the body via the bloodstream.
The	 indirect	 link	 suggests	 that	 individuals	 with	 periodontitis	 have	 a	 hyper-inflammatory	
response,	 characterized	by	 increased	plasma	 levels	 of	 proinflammatory	 cytokines	 such	 as	
interleukin-1β,	interleukin-6,	and	tumor	necrosis	factor-alpha.121 These cytokines promote the 
atherosclerotic	process	in	the	vessel	wall,	whereby	the	inflammatory	response	encourages	the	
aggregation and adhesion of platelets, activates leukocytes, and attracts cholesterol.29,32 The 
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periodontal	inflammatory	lesion	also	causes	release	of	lipopolysaccharides.	This	activates	the	
endothelial function to express more adhesion molecules, which then attract monocytes and 
results in the formation of foam cells (Figure 9).120,122-125 
The suggestion of a direct link is based on the theory that periodontal pathogens actually reach 
systemic circulation and enter the endothelium of the vessel wall. Once in the endothelium, 
it	is	suggested	that	the	pathogens	heighten	defense	reactions	via	an	inflammatory	response,	
which attracts even more immune cells and induces the migration of foam and smooth 
muscle cells; the atherosclerotic plaque core continues to grow while the surrounding 
fibrous	cap	thins.120,126 Deoxyribonucleic acid (DNA) from oral pathogens has been found in 
atherosclerotic plaque.127-129 However, studies have yet to demonstrate that bacteria induce 
plaque formation. 
PERIODONTAL INTERVENTION AND CARDIOVASCULAR DISEASE
How periodontal treatment affects the development of cardiovascular events or their 
complications is still unclear. Intervention studies have used surrogate markers for, periodontitis 
such	 as	 inflammatory	markers	 and	markers	 of	 subclinical	 cardiovascular	 disease.38,44,130-132 
Studies	 have	 shown	 that	 periodontal	 treatment	 decreases	 levels	 of	 inflammatory	markers	
such	 as	 interleukin-6,	 fibrinogen,	 total	 cholesterol	 and	 high	 sensitivity	C-reactive	 protein	
(hsCRP)133-135 and improve endothelial function. Until now, only one multicenter pilot study 
has investigated the effects of periodontal intervention on secondary prevention of cardiac 
events, the Periodontitis and Vascular Events (PAVE) study.136,137 Patients with periodontitis 
and a history of cardiovascular disease (angiographically proven coronary artery disease 
or recent myocardial infarction or surgical or PCI revascularization) were randomized to 
community dental care or a special program including oral hygiene instructions and nonsurgical 
periodontal	 intervention.	At	 the	 25-month	 follow-up,	 there	 was	 no	 significant	 difference	
Figure 9. Flow chart illustrating potential associations between periodontitis and cardiovascular 
disease. An individual with a hyper-inﬂammatory response, in combination with bacterial dysbiosis 
and the presence of risk factors, is more prone to develop periodontitis. Periodontitis leads to a 
systemic spread of bacteria, which may cause vascular changes, and increase the risk of developing 
atherosclerosis. Nordendahl 2019 (Unpublished)
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between the groups in occurrence of adverse cardiovascular events or in the results of the 
periodontal intervention after one year. One suggestion as to why there was no difference 
between the groups was that the group attending community dental care received additional 
periodontal therapy outside the study. A Systematic Cochrane review from 2017 concluded 
that the evidence was inadequate to support the theory that periodontal intervention can 
prevent the recurrence of cardiovascular disease in patients with periodontitis.84 
ORAL INVASIVE TREATMENT AND CARDIOVASCULAR DISEASE
The	microflora	 in	 the	oral	 cavity	consists	of	more	 than	one	 thousand	bacterial	 species.138 
Bacteremia originating in the oral cavity may occur when bacteria penetrate the ulcerated 
epithelia of pathological periodontal pockets or from bacterial invasion in damaged tissue 
after dental extraction. Invasive oral treatment has been suggested to lead to an acute 
inflammatory	response.139 Furthermore, it has been described that bacteremia occur after dental 
extractions, although short-lived.140,141 Whether such bacteremia after dental procedures may 
have an impact on the development of cardiovascular disease is not clear. However, there 
are	 indications	 that	 after	 general	 surgery,	 bacterial	 infections	 and	 acute	 inflammation	 are	
associated with a short-term increased risk of developing vascular events.142 The knowledge 
about	immune	inflammatory	and	stress	response	in	relation	to	invasive	dental	procedures	is	
sparse.	In	a	prospective	intervention	study	inflammatory	markers	(interleukin-6	and	hsCRP)	
increased 24 hours after intensive periodontal therapy.131	After	one	week,	all	inflammatory	
markers	 were	 normalized,	 indicating	 that	 the	 inflammatory	 response	 might	 be	 transient.	
Another	study	presented	an	increased	risk	of	vascular	events	during	the	first	four	weeks	after	
an invasive dental procedure, however when only analyzing events of myocardial infarctions, 
there was no increased association.139
SUMMARY AND GAPS IN KNOWLEDGE 
The association between periodontitis and myocardial infarction is still not fully understood. 
The amount of research into this association is vast, but of varying quality, mainly due to 
methodological considerations. Furthermore, impact of gender, is less explored.
In Sweden, where medical health and dental care hold high standards and where nationwide 
registry data on cardiovascular disease and dental care are available, opportunities for 
studying such research questions are unique compared with many other countries. Access 
to these national registries also allows the study of how invasive dental treatment affects 
vascular events in large populations.
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AIMS
The general aim of this thesis was to increase our knowledge of the relation between oral 
health and cardiovascular disease, in particular the association between periodontitis, invasive 
oral	treatment	and	a	first	myocardial	infarction.	Specific	aims	were	to	test	the	hypotheses	that:
I.	 Periodontitis	is	associated	with	a	first	myocardial	infarction	in	a	prospective	case-control	
study (Study I) and in a nationwide registry cohort (Study III), in contemporary settings.
II.	 The	association	between	periodontitis	and	a	first	myocardial	 infarction	differs	between	
men and women (Study II).
III.	 Invasive	dental	treatment	is	associated	with	the	incidence	of	a	first	myocardial	infarction	
(Study IV).
Eva Nordendahl
30
MATERIALS AND METHODS
STUDY DESIGN
Table 5. Descriptions of the four studies in this thesis.
Study I Study II Study III Study IV
Study 
design
Multicenter 
case-control with 
prospective data
PAROKRANK
Multicenter case-
control with 
prospective data
PAROKRANK
Registry-based case-
control 
Registry-based case-
control
Data
source
The PAROKRANK 
database
The PAROKRANK 
database
NBHW: The  IPR, The 
DHR, The SPDDR, and 
The Cause of Death 
register
SCB: The TPR and LISA
NBHW: The  IPR, The 
DHR, The SPDR, and 
The Cause of Death 
register
SCB: The TPR and LISA
Study 
population
Cases: Patients ≤75 
years with a first 
MI admitted to 1 
of 17 participating 
hospitals (n = 805)
Controls: The 
TPR matched for 
age, gender and 
geographic area, no 
previous MI 
(n = 805)
Cases: Patients 
≤75 with a first MI 
admitted to 1 of 17 
participating hospitals 
(n = 785)
No X-rays were 
excluded
Controls: The 
TPR matched for 
age, gender and 
geographic area, no 
previous MI 
(n =  792)
No X-rays were 
excluded
Cases: Individuals in 
Sweden with a first MI 
(n = 51,880)
Controls: Individuals 
in Sweden matched 
5:1, for age, gender 
and geographic 
area, no previous MI 
(n = 246,978)
Cases: Individuals in 
Sweden with a first MI 
(n = 51,880)
Controls: Individuals 
in Sweden matched 
5:1, for age, gender 
and geographic area 
and no previous MI (n 
= 246,978)  
Enrollment 2010−2014 2010−2014 2011−2013 2011−2013
Exposure Periodontitis 
(Radiographic)
Periodontitis 
(Radiographic)
Periodontitis (DHR 
periodontal treatment 
codes)
Invasive dental 
treatments (DHR 
dental treatment 
codes)
Outcome A first MI A first MI A first MI A first MI
Adjustments Matched variables 
(age, gender, 
geographic area of 
residence), diabetes, 
smoking, education, 
and marital status
Age, diabetes, 
smoking, education, 
and marital status
Matched variables 
(age, gender, 
geographic area of 
residence), diabetes, 
previous CVD, CVD 
drug treatment, 
education, and 
income.
Matched variables 
(age, gender, 
geographic area of 
residence), diabetes, 
education, and 
income.
Statistical 
tests
Student’s t-test, 
McNemar’s 
test,  Wilcoxon 
signed rank test, 
conditional logistic 
regression
Student’s t-test, chi-
squared test, logistic 
regression
Student’s t-test,  
chi-squared test, 
conditional logistic 
regression
Student’s t-test,  
chi-squared test, 
conditional logistic 
regression
CVD = cardiovascular disease, DHR = Dental Health Registry,  IPR =  National Inpatient Register, LISA = Longitudinal 
integration database for health insurance and labour market studies, MI = myocardial infarction, NBHW = National 
Board of Health and Welfare,  PAROKRANK = Periodontitis and Its Relation to Coronary Artery Disease study, SCB 
= Statistics Sweden, SPDR = Swedish Prescribed Drug Register, TPR = Total Population Register
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DATA SOURCES
The present thesis investigated two study populations. 
Studies I and II based their analyses on the Periodontitis and Its Relation to Coronary Artery 
Disease (PAROKRANK) study cohort data, which was prospectively collected during 
2010−2014. The study population comprised patients (cases) which were included during 
hospitalization	of	a	first	myocardial	infarction,	who	were	admitted	to	1	of	17	participating	
Swedish hospitals (Figure 10), were younger than 75 years of age, and had no heart valve 
replacement. The controls were chosen from the National Population Registry; were 
matched by age, gender and geographic area of living (postal code) and free of myocardial 
infarction and heart valve replacement. Study nurses at the coordinating center (Cardiology 
Unit, Department of Medicine at Karolinska Institutet) contacted the controls, who were 
then examined at their local center. The myocardial infarction diagnosis was according to 
international criteria for acute STEMI or acute NSTEMI.143,144
Studies III and VI retrieved their data from Swedish national registers, the National Board 
of Health and Welfare (NBHW), and Statistics Sweden (SCB; Figure 12). The Swedish 
personal identity number (PIN) makes it possible to link data on an individual in Sweden 
between the various nationwide registers. The PIN was introduced in 1947 and is assigned 
to all individuals who have resided in Sweden on a permanent basis at any time.145 Studies 
III and IV used	a	myocardial	infarction	diagnosis	based	on	the	International	Classification	of	
Diseases (ICD-10 code I.21), as recorded in the Swedish National Patient Register (IPR).146 
Figure 10. Map of the participating hospitals in Studies I & II: Akademiska sjukhuset, Uppsala; 
Centralsjukhuset, Karlstad; Centralsjukhuset, Kristianstad; Danderyds sjukhus, Stockholm; 
Centralsjukhuset, Växjö; Falu lasarett, Falun; Karolinska Universitetssjukhuset, Huddinge; Karolinska 
Universitetssjukhuset, Solna; Kärnsjukhuset, Skövde; Mölndals sjukhus; Norrlands Universitetssjukhus, 
Umeå; Sahlgrenska Universitetssjukhuset, Göteborg; Skellefteå lasarett; Södersjukhuset AB, Stockholm; 
Skånes Universitetssjukhus, Lund; Universitetssjukhuset, Örebro; and Västmanlands sjukhus, Västerås. 
(Site investigators listed in the original article61).  
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Study procedures (Studies I & II)
Study participants fasted and refrained from smoking for 12 hours before their visit at 
the cardiology department. The physical examination included measurements of heart 
rate, blood pressure after 5 minutes of rest in a sitting position, height, body weight, and 
waist circumference. The national quality registry SWEDEHEART147 was used to collect 
medical information from the patients at the time of their initial hospitalization (Swedish 
Register of Information and Knowledge about Swedish Heart Intensive Care Admissions) 
and at the secondary prevention follow-up (Secondary Prevention after Heart Intensive Care 
Admission) 6 to 10 weeks after the myocardial infarction. Corresponding information was 
collected for the control population.
Laboratory measurements 
All patients with no known diabetes were administered the oral glucose tolerance test 
(OGTT; 75 g glucose in 200 mL water). Venous P-glucose was sampled 2 hours after glucose 
intake while the patient was fasting (point-of care HemoCue 201; HemoCue AB, Ängelholm, 
Sweden).
Venous blood samples: A local laboratory analyzed complete blood count, phospholipids 
(total	and	high-density	lipoprotein	cholesterol	and	triglycerides),	P-creatinine,	P-fibrinogen,	
P-glucose, and glycohemoglobin A1c (HbA1c). 
High-sensitive C-reactive protein: A central laboratory (redhot diagnostics AB, Södertälje, 
Sweden) carried out the quantitative determination of hsCRP with a functional sensitivity of 0.1 
mg/L using an enzyme-linked immunosorbent assay method (MP Biomedicals, New York, NY 
USA). 
Questionnaire: All cases and controls completed a questionnaire requesting information on 
medical and family history, risk and health preserving factors, and the Montgomery Åsberg 
Depression Rating Scale.148 
Dental examination (Studies I & II)
A dentist or a dental hygienist at a local hospital dental clinic examined all study participants 
according to a standardized procedure. Included in the examination were 28 teeth; third molars 
were excluded from the examination. Complete or partial dentures and complete implant bridges 
were	classified	as	removable	dentures.	A	periodontal	pocket	was	considered	pathological	when	
the probing pocket depth exceeded 4 mm and was noted as a continuous variable. Gingival 
inflammation,	bleeding	on	probing,	was	expressed	as	the	proportion	of	bleeding	sites	among	
all sites in the dentition. Digital or analog panorama radiographs were made of all participants, 
whether dentate or edentulous. 
All panoramic X-rays were sent to the Department of Dental Medicine, Karolinska Institutet 
Huddinge, for central analysis with ImageJ (Image Tool 3.0, Department of Dental Diagnostics 
Science, University of Texas Health Science Center, San Antonio, TX): Three trained dentists 
at the core center made all measurements using a high-resolution computer monitor in a 
darkened room. The dentists were blinded to the group status (case or control) of the radiograph. 
Measurements from the marginal bone crest to the tooth apex and from the cementoenamel 
junction to the tooth apex were made at the site with the most pronounced bone loss for each 
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tooth with visible cementoenamel junctions and apices (Figure 11); dental implants and third 
molars were excluded. Total bone height was used to calculate the proportion of remaining 
bone height for each tooth and determine the arithmetic mean of all examined teeth for each 
participant. 
Based on mean remaining bone height, cases and controls were placed in one of three groups: 
healthy	 (≥	 80%	 remaining	 bone),	 mild	 to	 moderate	 periodontitis	 (79−66%),	 and	 severe	
periodontitis	(<	66%).	The	three	dentists	were	calibrated	using	42	randomly	selected	panoramic	
X-rays.	All	three	were	in	full	agreement	concerning	mean	remaining	bone	height	on	121	(96%)	
of the radiographs. The correlation between dentists 1 and 2 was 0.95; between 1 and 3, 0.90; 
and between 2 and 3, 0.90.
The National Inpatient Register (Studies III & IV)
The NBHW established the IPR in 1964 to manage the collection of nationwide data on 
somatic inpatient care. 149 In 1987, the IPR achieved complete coverage with collection of data 
on	more	than	99%	of	all	somatic	and	psychiatric	hospital	discharges.	The	register	classifies	
diagnoses	according	to	the	Swedish	International	Classification	of	Disease	(ICD,	based	on	the	
World Health Organization ICD) system.146,149 The positive predictive value of diagnoses in 
this register is around 85−95%.
Studies III and IV	obtained	data	on	first	time-registered	diagnoses	of	myocardial	infarction	for	
cases and on other health events for all study participants from the IPR. To preserve patient 
anonymity, the NBHW replaced all PINs with coded serial numbers before releasing the data.
The Dental Health Register (Studies III & IV)
The Dental Health Register (DHR) began collecting data on the dental health of the population 
in 2008 and administers data on the dental health of all residents aged 19 years and older. 
Figure 11. Radiographic measurements from the marginal bone to the tooth apex (yellow line – 
bone height) and from the cementoenamel junction to the tooth apex (blue line – total root length) 
for calculating the proportion of remaining bone. Reproduced with permission from Rydén et al, 
Periodontitis Increases the Risk of a First Myocardial Infarction: A Report From the PAROKRANK 
Study, Circulation. 2016;133:576-83.61 (Study I)
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The Swedish Insurance Agency is involved in government reimbursements of dental care 
providers and administrates data collection.150 The NBHW, which is the register holder of the 
DHR, collects information on dental health from the Swedish Insurance Agency. All dental 
health	care	providers	connected	to	the	dental	reimbursement	system,	approximately	99%,	are	
obligated to report all performed dental treatments electronically.151
The DHR contains information on number of remaining teeth, number of intact teeth, diagnoses, 
and dental treatments. A dental diagnosis is only recorded in the register when it is combined 
with	 a	 performed	 dental	 intervention.	 The	 Dental	 and	 Pharmaceutical	 Benefits	Agency	 of	
Sweden	sets	up	the	classifications	for	the	diagnoses	and	dental	procedures	and	determines	the	
level of reimbursement for these procedures.152 
Through linkage of the PIN to the DHR, Studies III and IV were able to retrieve information on 
dental interventions and treatments for all study participants. 
Periodontal treatment (Study III)
Periodontal	 treatment	 was	 classified	 as	 either	 non-advanced	 or	 advanced.	 Non-advanced	
treatment	 included	 supra-gingival	 curettage	 or	 non-specific	 periodontal	 treatment	 with	 a	
periodontal diagnosis. Advanced treatment included sub-gingival curettage and/or periodontal 
surgery with a periodontal diagnosis. Four categories of treatment were created based on the 
treatment and diagnosis codes in the DHR (Appendix 1):
(i) No record of dental treatment.  
(ii) No record of periodontal treatment.
(iii) One or more records of non-advanced periodontal treatment.
(iv) One or more records of advanced periodontal treatment.
Invasive dental treatment (Study IV)
Invasive	 dental	 treatment	 was	 defined	 as	 one	 or	 more	 of	 the	 following	 dental	 procedures	
registered in the DHR (Appendix 2): 
(i) Sub-gingival curettage
(ii) Dento-alveolar surgery and/or tooth extractions 
(iii) Implant surgery 
(iv) Periodontal surgery 
(v) Apical surgery
The Swedish Prescribed Drug Register (Studies III & IV)
The Swedish Prescribed Drug Register (SPDR) was established in July 2005 and is maintained 
by the NBHW.153 This register contains data on all dispensed prescription drugs for residents 
throughout Sweden. Two research groups have validated the SPDR through cross-referencing 
with patient medical records.153,154 
Studies III and IV obtained information from the SPDR on all dispensed prescription drugs for 
the study participants.
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The Cause of Death Register (Studies III & IV)
The NBHW manages the Cause of Death Register, which has had national coverage since 1952. 
The Cause of Death Register archives information on the date of death and primary causes of 
death for all residents in Sweden and deaths of Swedish citizens that occurred abroad.155 
Studies III and IV retrieved information from the Cause of Death Register on the time of death 
of deceased study participants. 
The Total Population Register (Studies III & IV)
The Total Population Register (TPR) is a merger of several national registers; the SCB 
has maintained it since 1961.156 The primary mandate of the TPR is to gather information 
on individuals residing in Sweden, such as birth, marriage, death, change of name, 
highest educational level, and family relation. This register is a fundamental instrument in 
epidemiological research in Sweden. Due to indexing with the Swedish PIN, the TPR can be 
linked with other national registers and is invaluable for identifying controls in studies.
 
Studies III and IV	 identified	potential	controls	 from	 information	provided	by	 the	TPR.	The	
control group was formed using risk set sampling, a random selection procedure which included 
sampling with replacement. The controls were matched at a ratio of 5:1, for age, gender, and 
geographic area of residence.
Figure 12. Flowchart of case-and-control selection from registers maintained by The National Board 
of Health and Welfare (NBHW) and Statistics Sweden (SCB, Studies III & IV). MI = myocardial infarct; 
PIN = the Swedish personal identity number; ICD-10 121 = International Classification of Disease, 
Swedish version, code for MI; 2001–2014 = database search of years 2001 - 2014. 
Inpatient register (NBHW)
ICD-10 I21, 2001-2014 
(n=222,251)
Excluded
Prior MI (n=89,210)
More than one PIN (n=231)
No matched control subject (n=8)
Excluded
First MI event < 2011 and > 2013  
(n=80,922)
n = 132,802
n = 51,880
Cases with a first MI
Population register (SCB)
Matched for age, gender, 
and geographic area  
(n=1,111,142)
Excluded
Prior MI (n=11,249)
Deceased (n=897)
More than one PIN (n=271)
No matched control (n=851,747)
n = 246,978
Matched controls (5:1)
Additional information retrieved from the NBHW and the SCB
Records of cardiovascular disease, diabetes, cardiovascular drug treatment, 
and dental treatment; socioeconomic information
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The Longitudinal integration database for health insurance and labour market studies 
– LISA (Studies III & IV)
The Longitudinal integration database for health insurance and labour market studies (LISA) is 
a database that consolidates information from several national registers. It registers longitudinal 
data related to the life situation, health, work, and and labour market of residents in Sweden.157
Studies III and IV procured information from the LISA on cases and controls concerning 
education level, income, and socioeconomic status. 
STATISTICAL METHODS 
Studies I and II used a power calculation to determine the group size necessary for detecting an 
increased	risk	of	myocardial	infarction	with	a	power	of	80%	(OR	=	1.4).	The	calculation,	based	
on	the	first	120	cases	and	120	controls,	found	that	800	cases	and	800	matched	controls	would	
be	needed	to	detect	a	difference	in	myocardial	infarction	risk	with	a	95%	level	of	confidence.	
Study I used the Student’s t-test, a common test for analyzing normally distributed means, 
to compare the differences between continuous variables. The McNemar test and Wilcoxon 
signed-rank test were used to compare differences between categorical values. To estimate 
the effect of the risk on the outcome in a matched study population, a conditional logistic 
regression modeling was used. Regression analyses investigated whether periodontitis was 
associated	with	an	increased	incidence	for	a	first	myocardial	 infarction	after	controlling	for	
potential confounders: matched variables (age, gender, and geographic area of living [postal 
code]), diabetes, smoking, education, and marital status. 
In Study II, the chi-squared test analyzed differences in categorical variables between cases and 
controls. The Student’s t-test was used to compare differences between continuous variables. 
Study II was a post hoc analysis of data from Study I,	stratified	by	gender.	Logistic	regression	
modelling	 analyzed	 the	 association	 between	 severe	 periodontitis	 and	 a	 first	 myocardial	
infarction. The regression analyses were adjusted for diabetes, previous cardiovascular disease, 
cardiovascular drug treatment, education, and income. 
Studies III and IV used the chi-squared test to analyze the differences in categorical variables 
between cases and controls. The Student’s t-test was used to compare differences between 
continuous variables. In Study III, conditional logistic regression modeling analyzed the 
association between periodontitis, using periodontal treatment as a surrogate marker, and a 
first	myocardial	infarction	after	adjusting	for	relevant	confounders:	diabetes,	education,	and	
income. In Study IV, conditional logistic regression modeling investigated the association 
between	invasive	dental	treatment	and	a	first	myocardial	infarction.	The	regression	analyses	
were adjusted for matched variables (age, gender, and geographic area of residence), diabetes, 
previous cardiovascular disease, cardiovascular drug treatment, education, and income. 
The	relative	risk	estimates	are	presented	as	ORs	with	95%	confidence	intervals	(CIs);	in	all	
four studies, a two-sided p-value	of	<	5%	was	considered	significant.	Studies I−IV used SAS 
system statistical software (The SAS system for Windows version 9.4, SAS Institute Inc., Cary, 
NC, USA) for all analyses.
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ETHICAL CONSIDERATIONS 
The four studies in this research project followed the ethical principals for medical research laid 
out in the Declaration of Helsinki and were conducted in accordance with current legislation 
in Sweden. The Regional Ethics Committee in Stockholm approved all studies: Studies I and 
II (Daybook no.: 2008/152-31/2) and Studies III and IV (Daybook no.: 2015/279-31/1). The 
Swedish Radiation Safety Authority also approved Studies I and II (Daybook no.: 2/08).
Before enrollment in Studies I and II, participants gave their written, informed consent to 
participate in the study. Participants could withdraw from the studies at any time. The risks for 
the patients and controls in Studies I and II were small. All investigators and study coordinators 
were experienced, and the added risks for the individuals participating in the study were 
considered small. The examinations are well established in clinical practice. Blood sampling 
and dental examinations can cause minor discomfort. The additional radiation from the X-rays 
in the study was small, and the Radiation Protection Committee approved the examination. The 
advantages of the study to the patient included a thorough medical and dental examination that 
compensates for the relatively small risks. In those cases where a dental or medical condition 
needed treatment or follow-up, the participants were advised how to proceed. 
Data in Studies III and IV were from Swedish national registers where no informed consent 
was required from the participants (according to The Patient Data Act 2008:355). Appendices 
1 and 2 describe the codes used by the IPR, the SPDR, and the DHR. The NBHW replaced the 
PIN of each individual with a coded serial number before releasing any information in order 
to preserve anonymity. 
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RESULTS
STUDY I
In total, 922 cases were included but 117 withdrew their consent before the study visit. 
Remaining were 805 cases and 805 matched controls who underwent the study procedures. 
The ratio of men:women was 81:19; mean age was 62±8 years (Table 6). 
Table 6. Clinical characteristics in Study I. 
Data are presented as mean ± SD or number (%).Information on pharmacological treatment and 
smoking habits in patients were registered at the time for hospital admission.
Cases Controls p 
Characteristics n=805 n=805
Age (years) 62±8 62±8 NS
Men 654 (81) 654 (81) NS
Family history of CVD 302 (38) 183 (23) <.001
Medical history
   Hypertension 286 (36) 268 (34) NS
   Peripheral artery disease 20 (3) 10 (1) NS
   Stroke 22 (3) 18 (2) NS
   Diabetes 79 (10) 65 (8) NS
   Rheumatic disease 164 (21) 136 (17) NS
   Pulmonary disease 106 (14) 85 (11) NS
   Kidney disease 33 (4) 32 (4) NS
   Cancer 66 (8) 58 (7) NS
   Depression 76 (9) 71 (9) NS
Pharmacological treatment 
   Renin-angiotensin inhibitors 194 (24) 213 (27) NS
   Aspirin 90 (11) 82 (10) NS
   Beta-blockers 116 (15) 106 (13) NS
   Statins 119 (15) 134 (17) NS
   Anti-inﬂammatory agents (NSAID) 15 (2) 32 (4) 0.018
   Corticosteroids 26 (3) 30 (4) NS
Number of Teeth 24±6 25±5 <0.001
Smoking habits 
   Current 206 (26) 96 (12)
   Previous 286 (36) 361 (45) <0.001
   Never 297 (38) 348 (43)
Waist circumference (cm) 99±11 98±12 NS
Body Mass Index (kg/m2) 27±4 27±4 NS
Blood pressure (mm Hg)
   Systolic 129±17 137±17 <0.001
   Diastolic 77±10 84±10 <0.001
CVD = cardiovascular disease
          Oral Health and Myocardial Infarction
39
Clinical characteristics
No	 significant	 between-group	 differences	 were	 observed	 in	 variables,	 such	 as	 history	 of	
hypertension, stroke, rheumatic disease, pulmonary disease, or cancer (Table 6). A family 
history of cardiovascular disease was more common among cases (Table 6). Cases were 
more frequently smokers upon admission to hospital, but by the time of the study visit, this 
difference between groups had disappeared (Table 6). There was no difference in proportions 
with	established	diabetes	among	the	groups	(cases	10	vs.	controls	8%;	p<0.250; Table 6). 
After	including	individuals	with	newly	detected	diabetes,	153	(19%)	cases	and	107	(13%)	
controls, in the established diabetes group diabetes became more common among cases than 
controls	(9	vs.	5%;	p<0.003).
Treatment with cardiovascular drugs did not differ between groups at hospital admission (Table 
6). By the time of the follow-up, more cases than controls were being treated with cardiovascular 
drugs, resulting in lower blood pressure and lipids among cases compared to controls.
Socioeconomic factors
Education	level	and	occupation	differed	non-significantly	between	groups.	Annual	household	
income	was	significantly	lower	among	cases	compared	to	controls	(13	vs	11%;	p<0.048) and 
cases	were	significantly	more	often	divorced	(15	vs.	10%;	p<0.046).  
Clinical dental characteristics 
Cases had fewer remaining teeth (24±6 vs. 25±5; p<0.001; Table 6) and more mild to moderate 
or	severe	periodontitis	(43	vs.	33%;	p<0.001) compared to controls (Figure 13). 
Periodontitis	 increased	 the	 risk	 of	 a	 first	 myocardial	 infarction	 (crude	 OR	 1.46;	 95%	 CI:	
1.19−1.80).	After	 adjusting	 for	 relative	 confounders	 −	 diabetes,	 smoking	 habits,	 years	 of	
education,	and	marital	status	−	the	positive	association	between	periodontitis	and	myocardial	
infarction	remained	(OR	1.28;	95%	CI:	1.03−1.60;	Figure	14).	
Crude 1.49 [1.19-1.80]
Adjusted 1.28 [1.03-1.60]
0.5 1.0 1.5 2.0 2.5
Figure 14. Associated risks (Odds ratios with 95% CIs) between periodontitis and a first myocardial 
infarction. Adjusted for diabetes, smoking, marital status and education. Cases [458/339] vs. controls 
[530/266]. (Study I)
Figure 13. Frequency (%) of periodontal status among the case and control groups. (A) Healthy, mild-
moderate, and severe. (B) Healthy, and mild-moderate or severe. (Study I) 
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STUDY II
Study II	stratified	the	analyses	by	gender	and	age.	The	case-control	comparisons	for	women	
were 147:147 and for men, 638:645. Mean ages were 64±7 years for women and 62±8 for 
men (Table 7). 
Case-control comparison among women 
Women cases had a higher frequency of hypertension, pulmonary disease, and diabetes and were 
more often being treated with aspirin and beta-blockers compared to controls (Table 7). Severe 
periodontitis	was	also	more	frequent	among	cases	than	controls	(14	vs.	4%;	p=0.005; Figure 15).
Among	women,	the	association	between	severe	periodontitis	and	a	first	myocardial	infarction	
was	significant	(adjusted	OR	3.72;	95%	CI:	1.24−11.16;	Figure	16).
Case-control comparison among women by age group ≤65 and >65 years
In	 the	65-year	and	under	age	group	of	women,	severe	periodontitis	 (16	vs.	3%;	p=0.007; 
Figure	15)	and	diabetes	were	significantly	more	common	in	cases	than	controls	and	statins	
were	more	frequently	prescribed	at	admission	to	hospital	for	the	first	myocardial	infarction,	
(Table 8). Among women below 65 years, the association between severe periodontitis and 
a	first	myocardial	infarction	was	significant	(OR	6.75;	95%	CI:	1.46−31.31),	and		remained	
after	adjustment	(OR	5.26;	95%	CI:	1.03−26.76;	Figure	16).
Table 7. Clinical characteristics in Study II of women and men separated by group. Data are pre-
sented as mean±SD or number (%). Information on pharmacological treatment and smoking habits 
in patients were registered at the time for hospital admission.
Women Men
Characteristics
Case
n= 147
Controls
n=147 P
Cases
n=638
Controls
n= 645 P
Age (years) 64±7 64±7 NS 62±8 62±8 NS
Family history of CVD 61 (42) 42 (29) NS 231 (36) 137 (21) <.001
Medical history
   Hypertension 62 (42) 44 (30) 0.029 218 (34) 220 (34) NS
   Diabetes mellitus 34 (23) 12 (8) <.001 116 (18) 92 (14) 0.048
   Pulmonary disease 30 (21) 16 (11) 0.020 71 (11) 64 (10) NS
   Rheumatic disease 52 (36) 51 (35) NS 108 (17) 83 (13) NS
Pharmacological treatment
   Renin-angiotensin inhibitors 14 (10) 12 (8) NS 89 (14) 86 (13) NS
   Aspirin 23 (16) 10 (7) 0.015 65 (10) 69 (11) NS
   Beta-blockers 32 (22) 16 (11) 0.011 82 (13) 88 (14) NS
   Statins 31 (21) 21 (14) NS 85 (13) 110 (17) NS
Number of teeth 23±5 24±5 NS 24±5 24±5 NS
Smoking habits
   Current/Previous 93 (65) 83 (56)
NS
381 (61) 365 (57)
NS
   Never 51 (35) 64 (43) 245 (39) 280 (43)
CVD = cardiovascular disease 
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1      3.72 [1.24-11.16]
2      1.67 [0.97-2.84]
3      5.26 [1.03-26.76]
4      1.16 [0.62-2.18]
5      2.62 [0.70-9.79]
6      2.98 [1.12-7.91]
0 1 2 3 4 5 6 7 8 9 34
Figure 16. Associated risks (Odds ratios with 95% CIs) between severe periodontitis and a first 
myocardial infarction by gender and age-groups. All analyses were adjusted for age, smoking, 
diabetes, education, and marital status. (1) Women: cases [126/21] vs. controls [141/6]; (2) Men: 
cases [593/45] vs. controls [620/25]; (3) Women ≤65: cases [65/12] vs. controls [72/2]; (4) Men ≤65: 
cases [382/28] vs. controls [386/19]; (5) Women >65: cases [62/9] vs. controls [69/4]; (6) Men >65: 
cases [211/17] vs. controls [234/6]. (Study II)
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Figure 15. Frequency (%) of periodontal status by gender. (A) Women. (B) Men. Data are shown for 
all participants and for participants stratified by age: ≤65 and >65 years.(Study II)
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The over 65-year age group of women had a higher frequency of hypertension, diabetes, and 
pulmonary disease compared to their matched controls (Table 8). Severity of periodontitis 
did	not	differ	significantly	between	the	two	groups	(13	vs.	5%;	p=0.313; Figure 15). Among 
women	over	65	years,	 the	association	between	severe	periodontitis	and	a	first	myocardial	
infarction	was	non-significant	(adjusted	OR	2.50;	95%	CI:	0.73−8.54;	Figure	16).	
Case-control comparison among men 
Among men, family history of cardiovascular disease, diabetes and divorce were seen more 
often among men cases compared to controls (Table 7). Severe periodontitis was more 
common	in	men	cases	compared	to	controls	(7	vs.	4%;	p=0.005; Figure 15). Among men, the 
association	between	severe	periodontitis	and	a	first	myocardial	infarction	was	not	significant	
after	adjustments	(OR	1.67;	95%	CI:	0.97−2.84;	Figure	16).
Case-control comparison among men by age group ≤65 and >65 years
Among	men	aged	≤65	years,	cases	had	more	of	a	family	history	of	cardiovascular	disease,	
were more often smoking at the time of hospital admission and divorced or widowed in 
comparison with men controls (Table 9). The proportion of severe periodontitis was higher 
among	cases	compared	to	controls	(7	vs.	5%;	p=0.045; Figure 15). 
The	association	between	 severe	periodontitis	 and	myocardial	 infarction	was	non-significant	
between	men	cases	and	controls	≤65	years	(adjusted	OR	1.16;	95%	CI:	0.62−2.18; Figure 16). 
Table 8. Clinical characteristics in Study II of women ≤65 and >65 years separated by group. Data are 
mean±SD or n (%). Information on pharmacological treatment and smoking habits in patients were 
registered at the time for hospital admission. 
Women  ≤ 65 years of age Women > 65 years of age
Characteristics
Cases
n=76
Controls
n=74
P
Cases
n=71
Controls
n=73
P
Age (years) 59±6 58±6 NS 69±3 69±3 NS
Family history of CVD 28 (37) 23 (31) NS 33 (46) 19 (26) 0.031
Medical history
   Hypertension 25 (33) 18 (25) NS 37 (53) 26 (36) 0.038
   Diabetes 13 (17) 3 (4) 0.010 21 (30) 9 (12) 0.010
   Pulmonary disease 12 (16) 8 (11) NS 18 (26) 8 (11) 0.020
   Rheumatic disease 21 (28) 23 (32) NS 31 (44) 28 (3) NS
Pharmacological treatment
   Renin-angiotensin inhibitors 4 (5) 4 (5) NS 10 (14) 8  (11) NS
   Aspirin 7 (9) 5 (7) NS 16 (23) 5 (6) 0.008
   Beta-blockers 14 (19) 6 (8) NS 18 (25) 10 (14) NS
   Statins 18 (24) 5 (7) 0.004 13 (18) 16 (22) NS
Number of teeth 24±5 25±5 NS 22±5 24±5 NS
Smoking habits
   Current/Previous 54 (73) 44 (59)
NS
39 (56) 39 (53)
NS
   Never 20 (27) 30 (41) 31 (44) 34 (47)
CVD = cardiovascular disease
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In the over-65 age group of men, compared to controls, cases had more of a family history 
of cardiovascular disease and rheumatic disease (Table 9). Severe periodontitis was more 
frequent	among	cases	compared	 to	men	controls	 (7	vs.	3%;	p=0.023; Figure 15). Among 
men over 65 years, the association between severe periodontitis and myocardial infarction 
was	 significant	 (OR	3.14;	 95%	CI:	 1.22−8.12),	 and	 remained	 after	 adjusting	 for	 relevant	
confounders	(OR	2.98;	95%	CI:	1.12−7.91;	Figure	16).
STUDIES III & IV
The total study population comprised 51,880 cases and 246,978 controls. Nineteen percent 
(n=10,076)	of	the	cases	and	16%	(n=40,637)	of	the	controls	had	no	record	of	dental	visits	
during the study period. Mean ages were 72.6±13.0 years for cases and 72.3±13.0 for controls 
(Table 10). The gender ratios were 62 (men):38 (women) among cases and 61 (men):39 
(women) among controls (Table 10).
Characteristics of cases and controls (Studies III & IV)
Diabetes, fewer teeth, lower education level, and lower income were more frequent among 
cases than controls (Table 10). Cases with no record of dental treatment during the study period 
had lower education and a higher frequency of diabetes compared to controls. 
Diabetes	and	previous	cardiovascular	disease	(heart	failure,	atrial	fibrillation,	angina	pectoris,	
and stroke) were more common among cases than controls (Table 10). Cases also had more 
Table 9. Clinical characteristics in Study II of men ≤65 and >65 years separated by group. Data are 
mean±SD or n (%). Information on pharmacological treatment and smoking habits in patients were 
registered at the time for hospital admission.
Men ≤ 65 years of age Men > 65 years of age
Characteristics
Cases
n=410
Controls
n=405
P
Cases
n=228
Controls
n=240
P
Age (years) 57±7 58±7 NS 69±3 69±3 NS
Family history of CVD 166 (40) 97 (24) <.001 65 (29) 40 (17) 0.007
Medical history
   Hypertension 122 (30) 105 (26) NS 96 (42) 115 (48) NS
   Diabetes 62 (15) 49 (12) NS 54 (24) 43 (18) NS
   Pulmonary disease 36 (9) 40 (10) NS 35 (16) 24 (10) NS
   Rheumatic disease 54 (13) 48 (12) NS 54 (24) 35 (15) 0.010
Pharmacological treatment
   Renin-angiotensin inhibitors 50 (12) 42 (10) NS 39 (17) 44 (18) NS
   Aspirin 35 (9) 23 (6) NS 30 (13) 46 (19) NS
   Beta-blockers 48 (12) 38 (9) NS 34 (15) 50 (21) NS
   Statins 53 (13) 56 (14) NS 32 (14) 54 (23) 0.020
Number of teeth 25±4 26±4 NS 23±6 23±5 NS
Smoking habits
   Current/Previous 249 (62) 222 (55)
0.036
132 (59) 143 (60)
NS
   Never 152 (38) 183 (45) 93 (41) 97 (40)
CVD = cardiovascular disease
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Table 10. Clinical characteristics in Study III and IV of cases and controls. Data are presented as 
mean±SD or number (%), p-values compare cases and controls. 
Cases Controls P
Characteristics n=51,880 n=246,978
Gender
   Women 19,773 (38.0) 95,342 (39.0) NS
   Men 32,107 (62.0) 151,636 (61.0)
Mean age (years) 73±13 72±13 <0.001
Geographic areaa
    North 11,834 (22.8) 56,150 (22.7)
    Middle 16,652 (32.1) 79,538 (32.2) NS
    South 23,394 (45.1) 111,290 (45.1)
Education
    Primary school 22,130 (42.7) 95,432 (38.6)
    High school 20,377 (39.3) 94,333 (38.2) <0.001
    College/University 8,204 (15.8) 51,129 (20.7)
    Post graduate degree 338 (0.7) 2,596 (1.0)
    Missing data 831 (1.6) 3,488 (1.4)
Income (SEK/year)
     ≤ 99,000 7,567 (14.8) 3,3328 (13.6)
    100,000-299,000 38,232 (74.5) 178,173 (72.9) <0.001
    ≥ 300,000 5,508 (10.7) 32,992 (13.5)
No. of teeth (mean (± SD)) 20 (±9) 21 (±8) < 0.001
Comorbidities 
    Diabetesb 9,931 (19.1) 26,707 (10.8) < 0.001
       Type 1c 1,181 (2.3) 1,924 (0.8)
       Type 2d 8,753 (16.9) 24,899 (10.1)
  Previous CVD 25,374 (48.9) 57,100 (23.1) <0.001
    Heart failure 8,265 (15.9) 12,716 (5.2) <0.001
    Atrial fibrillation 6,609 (12.7) 23,465 (9.5) <0.001
    Angina pectoris 14,102 (27.2) 15,272 (6.2) <0.001
    Stroke 6,286 (12.1) 21,754 (8.8) <0.001
Diabetes treatmente 
       Insulin (A10A) 5,033 (9.7) 10,590 (4.3)
< 0.001       Oral  (A10B) 6,110 (11.8) 18,821 (7.6)
CVD drug treatment 35,355 (68.2) 139,054 (56.3) <0.001
    Antihypertensive 27,395 (52.8) 104,063 (42.1) <0.001
    Statins 14,156 (27.3) 51,871 (21.0) <0.001
    Low dose aspirin 17,866 (34.4) 57,143 (23.1) <0.001
    Beta blockers 19,552 (37.7) 65,785 (26.6) <0.001
aNorth = counties of Värmland, Dalarna, Gävleborg, Västernorrland, Jämtland, Västerbotten, Norrbotten. Middle = Stockholm, 
Uppsala, Södermanland, Östergötland, Örebro, Västmanland. South = Jönköping, Kronoberg, Kalmar, Gotland, Blekinge, Skåne, 
Halland, Västra Götaland.
bDiabetes was defined based on the ICD-10 codes, E.10-E.14, or if the history noted a glucose-lowering therapy with an Anatomi-
cal Therapeutic Chemical (ATC) code of A10A or A10B. cICD code for type 1 diabetes E10 + ATC code short acting insulin A10AB 
6 months before the MI event. dPatients who didn’t fit the criteria for type 1 diabetes were classified as having type 2 diabetes. 
eregardless of type of diabetes
CVD = cardiovascular disease
prescribed cardiovascular drug treatment (antihypertensives, statins, low-dose aspirin, and 
beta-blockers) than controls (Table 10). Education level and income were lower among cases 
compared to controls (Table 10).
Periodontal treatments (Study III)
Cases	had	received	more	non-advanced	periodontal	treatment	than	controls	(14.8	vs.	14.6%;	
p<0.001), yet advanced periodontal treatment was more common among controls (19.8 vs. 
19.2%;	p<0.001). The annual frequency of advanced periodontal treatment was higher among 
cases	compared	to	controls	(1.5	vs.	1.4%;	p<0.001).
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In a conditional logistic regression analysis, individuals with no record of dental treatment had 
an	increased	risk	of	a	first	myocardial	infarction	(adjusted	OR	1.15;	95%	CI:	1.12−1.18;	Figure	
17).  In individuals receiving dental treatment, non-advanced periodontal treatment increased 
the	risk	of	myocardial	infarction	(adjusted	OR	1.06;	95%	CI:	1.03−1.09;	Figure	17).	However,	
risk of a myocardial infarction did not increase among individuals who underwent advanced 
periodontal	treatment,	with	or	without	surgery	(adjusted	OR	1.02;	95%	CI:	1.00−1.05;	Figure	
17).	A	 high	 annual	 frequency	 of	 advanced	 periodontal	 treatment	 (≥3	 visits	 for	 advanced	
treatment	and/or	≥1	periodontal	surgery	per	year)	increased	the	risk	of	myocardial	infarction	
(crude	 OR	 1.16;	 95%	 CI:	 1.02−1.30),	 but	 after	 adjustments,	 the	 risk	 was	 non-significant	
(adjusted	OR	1.14;	95%	CI:	1.00−1.29;	Figure	17).
Dental treatments (Study IV)
The exposure, dental treatment, was analyzed at three time intervals: 4 weeks, 2 weeks, and 2 
days before the index event. 
A  
1 1.15 [1.12-1.18]
2 1.06 [1.03-1.09]
3 1.02 [1.00-1.05]  
0.9 1.0 1.1 1.2
0.9 1.0 1.1 1.2
B
1 1.10 [1.00-1.20]
2 1.14  [1.00-1.29]
1.3
Figure 17.  Association between periodontal treatment and myocardial infarction presented as Odds 
ratios with 95% CIs. All analyses were adjusted for diabetes, income and education.
(A) Periodontal treatment within 3 years, prior to index event. No periodontal treatment was used 
as reference: cases n=24,174 and controls n=121,467; (1) No record of dental treatment: cases 
[10,076/24,174] vs. controls [40,637/121,467]; (2) ≥one non-advanced periodontal treatment: 
cases [7,686/24,174] vs. controls [35,948/121,467]; (3) ≥one advanced periodontal treatment with 
or without periodontal surgery: cases [9,944/24,174] vs. controls [48,926/121,467].
(B) Number of periodontal treatment per year, prior to index event. One visit with advanced 
periodontal treatment without periodontal surgery was used as reference: cases n=7,294 and 
controls n=36,833 ; (1) Two visits with advanced periodontal treatment without periodontal 
surgery: cases [1,656/7,294] vs. controls [7,561 /36,833]; (2) Three visits with advanced periodontal 
treatment with periodontal surgery: cases [773/7,294] vs. controls [3,469/36,833]. (Study III)
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Table 11. Dental treatments 4 and 2 weeks, and 2 days before the case patient’s myocardial infarction 
diagnosis and the corresponding index date for control subjects.  Data are presented as numbers (%)
Time interval 4 weeks 2 weeks 2 days
Cases Controls P Cases Controls P Cases Controls P
Characteristics n=51,880 n=246,978 n=51,880 n=246,978 n=51,880 n=246,978
Invasive dental 
treatments*
934 (1.8) 4,537 (1.8) 0.571 474 (0.9) 2,425 (1.0) 0.150 70 (0.1) 483 (0.2) 0.004
  Sub-gingival scaling 492 (52.7) 2,498 (55.0) 246 (51.9) 1,301(53.7) 39 (55.7) 251 (52.0)
  Surgery** 414 (44.3) 1,947 (42.9) 213 (44.9) 1,039 (42.9) 29 (41.4) 210 (43.5)
  Implant surgery 38 (4.1) 115 (2.5) 18 (3.8) 65 (2.7) 1 (1.4) 12 (2.5)
  Periodontal surgery 12 (1.3) 66 (1.5) 5 (1.1) 35 (1.4) 1 (1.4) 8 (1.7)
  Apical surgery 5 (0.5) 29 (0.6) 1 (0.2) 13 (0.5) 1 (1.4) 6 (1.2)
Other dental 
treatments 
Dental examination 3,059 (5.9) 16,578 (6.7) <.001 1,548 (3.0) 8,693 (3.5) <.001 261 (0.5) 1,759 (0.7) <.001
X-ray examination 839 (1.6) 4,113 (1.7) 0.434 427 (0.8) 2,159 (0.9) 0.253 67 (0.1) 415 (0.1) 0.045
Temporary treatment 432 (0.8) 2,337 (1.0) 0.014 221 (0.4) 1,206 (0.5) 0.061 38 (<0.1) 251 (0.1) 0.059
Caries treatment 605 (1.2) 3,819 (1.6) <.001 315 (0.6) 2,008 (0.8) <.001 48 (<0.1) 410 (0.2) <.001
Supra-gingival scaling/ 
prophylaxis
1,084 (2.1) 6,315 (2.6) <.001 520 (1.0) 3,256 (1.3) <.001 73 (0.1) 645 (0.3) <.001
Fillings 1,661 (3.2) 9,369 (3.8) <.001 862 (1.7) 5,060 (2.1) <.001 148 (0.3) 1,072 (0.4) <.001
Root canal treatment 183 (0.4) 1,145 (0.5) <.001 90 (0.2) 618 (0.3) 0.001 13 (<0.1) 123 (<0.1) 0.016
Fixed prosthodontics 378 (0.7) 1,981 (0.9) 0.085 203 (0.4) 1,049 (0.4) 0.284 31 (<0.1) 220 (<0.1) 0.036
Removable 
prosthodontics
157 (0.3) 635 (0.3) 0.067 86 (0.2) 335 (0.14) 0.096 14 (<0.1) 65 (<0.1) 0.932
Temporomandibular 
disorder treatment
18 (<0.1) 90 (0.1) 0.849 6 (<0.1) 52 (<0.1) 0.158 1 (<0.1) 12 (<0.1) 0.357
*Each individual could have more than one recorded procedure **Including tooth extractions
During the 4 weeks preceding the myocardial infarction, the frequency of invasive dental 
treatment	 was	 similar	 for	 cases	 and	 controls	 (1.8	 vs.	 1.8%;	 p=0.571; Table 11), the only 
exception was implant surgery, which was more frequent among cases (Table 11). General dental 
procedures and interventions; dental examinations, temporary treatments, caries treatment, 
supra-gingival	 scaling/prophylaxis,	 fillings,	 root	 canal	 treatment,	 and	 fixed	 prosthodontics	
were less frequently performed in cases compared to controls (Table 11). 
Invasive dental treatments during the 2 weeks prior to the myocardial infarction were similar 
for	cases	and	controls	 (0.9	vs.	1.0%;	p=0.150; Table 11). The frequency of invasive dental 
treatment performed 2 days before the myocardial infarction event was lower in cases compared 
to	controls	(0.1	vs.	0.2%;	p=0.004; Table 11). 
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Figure 18. Association between invasive dental treatments before the myocardial infarction diagnosis 
presented as Odds ratios with 95% CIs. All analyses were adjusted for diabetes, previous cardiovascular 
disease, cardiovascular drug treatment, education and income. Shown in brackets [cases/controls]. 
(1) 2 days before the myocardial infarction [70/483]; (2) 2 weeks before the myocardial infarction 
[470/2,410]; (3) 4 weeks before the myocardial infarction [934/4,537]. (Study IV)
1 0.71 [0.55-0.93]
2 0.92 [0.83-1.02]
3 0.98 [0.91-1.06]
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Figure	10	presents	the	association	between	invasive	dental	treatment	and	a	first	myocardial	
infarction. The invasive dental treatments performed 4 weeks before the myocardial infarction 
event were not associated with an increased risk of myocardial infarction (adjusted OR 0.98; 
95%	CI:	0.91−1.06;	Figure	18);	neither	was	treatment	performed	during	the	2 weeks before 
the	myocardial	infarction	event	(adjusted	OR	0.92;	95%	CI:	0.83−1.02;	Figure	18).	Treatment	
performed 2 days before the myocardial infarction event was associated with a decreased risk 
of	experiencing	a	myocardial	infarction	(adjusted	OR	0.71;	95%	CI:	0.55−0.93;	Figure	18).
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DISCUSSION
Cardiovascular disease and periodontitis, two major global health problems, cause considerable 
pain and suffering and are substantial burdens on the individual and society. The diseases 
are	closely	related,	and	the	most	probable	link	is	a	leakage	of	inflammatory	mediators	from	
the	 local	 periodontal	 lesion,	 driving	 a	 systemic	 low-grade	 inflammation	 and	 development	
of atherosclerosis.120	Research	in	this	field	has	been	ongoing	for	over	30	years,	but	whether	
this relation is causal is still unclear.83 To be able to offer men and women who are suffering 
from periodontitis and cardiovascular disease the best possible treatment, it is fundamentally 
important to understand the risks and relations. 
The major objective of this thesis was to improve our knowledge of the relation between 
oral health and cardiovascular disease, in particular concerning the association between 
periodontitis, invasive dental treatment, and myocardial infarction. This was explored by 
including prospectively collected cases and controls as well as contemporary and large study 
populations.	Even	though	the	results	of	this	thesis	allow	no	definitive	conclusion	on	whether	
the relationship between periodontitis and cardiovascular disease is causal, the studies were 
designed to yield results with more comprehensive reliability compared to previous reports. 
Study 1 concluded that periodontitis is a risk factor for myocardial infarction (OR 1.28) based 
on	objectively	verified	radiographic	bone	loss,	after	adjustment	for	several	confounders.	This	
agrees with previous studies of varying design that have had myocardial infarction as an 
outcome.42,43,56,58,60,62,63,68,73,75  One Swedish study reported a higher OR (2.69) when clinical 
and periodontal bone loss were combined as the exposure.42 Interestingly, this association was 
only seen in 40−60-year-old individuals, which is in line with the results of Study II: where 
periodontitis  was more strongly associated  to a myocardial infarction in women below 
age 65 (OR 3.72) than in men or older women. Another study reported an even higher OR 
(3.77) when the exposure was clinically judged attachment loss in a younger population of 
mean age 55 years.43 This suggests that the association between periodontitis and myocardial 
infarction might be higher at younger ages, which would explain the lower OR in Study 1 
compared to previous studies and Study II.  Furthermore, one could speculate if this suggests 
that	severe	periodontitis	at	younger	ages	reflects	a	hyper-inflammatory	response	which	could	
put individuals at an increased risk of developing both periodontitis and atherosclerosis. 
Oral health has improved considerably in the last 20 years in Sweden (Figure 3), with a 
parallel reduction in incidence and mortality of myocardial infarction (Figure 5).13,27 This 
is an achievement of a social health care system with high standards in dental care and 
secondary prevention programs for cardiovascular disease.158 In epidemiological studies, one 
important factor appears to be the years of enrollment of the patients, which seems to affect 
the relationship between periodontitis and cardiovascular disease. Stronger associations have 
been reported by earlier studies42,43,47,60,62,63,73 while more recent studies such Study 1 and 
others more often report a less strong or no association.75-78 Two studies conducted in high-
income countries where patients were enrolled in 2007−2009 reported no associated risk.77,78 
However, several methodological shortcomings might explain their results, for example, 
there	was	no	matched	control	population	and	the	definitions	of	periodontitis	were	vague. It is, 
however, interesting to speculate whether the association between the diseases is decreasing 
compared to reports from earlier studies. 
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The lack of association in Study III and the rather low OR in Study I could be a result of improving 
health trends and may explain the lower association compared to older data.42,43,47,60,62,63,73 Thus, 
if the results of Studies I and III accurately	reflect	the	association	between	severe	periodontitis	
and myocardial infarction in a contemporary Swedish setting, the results emphasize the 
importance of access to both preventive dental care and preventative cardiovascular care. The 
results of Studies 1 and III might not be generalizable to populations with other types of health 
care systems.
Study III	did	not	confirm	an	association	between	periodontitis	and	myocardial	infarction.	This	
was unexpected and surprising, since Study III included over 50,000 cases during the same time 
period as Study 1. Several possible explanations for this discrepancy come to mind. Firstly, 
Study III used a surrogate marker for periodontitis, a procedure code for periodontal treatment, 
that had not been previously validated. This treatment code was chosen as the exposure since 
it was the best available national registry code with information on periodontitis. However, it 
must be noted that these registry codes have not been validated against patient records. There is 
a risk that individuals who actually did not have periodontitis were given periodontal treatment 
and vice versa, thus diluting the OR toward null. Secondly, Study 1 might have introduced a 
selection bias towards more healthy controls, since those with worse oral health might have 
declined participation to a larger extent, thus strengthening the association. However, looking 
at Study III data again, cases with a high annual frequency of advanced periodontal treatments 
in combination with periodontal surgery presented a slightly increased risk of myocardial 
infarction	(OR	1.14).	Even	though	this	result	was	non-significant,	it	indicates	that	an	association	
might still be present in individuals with a severe level of periodontitis. Studies I and II present 
the level of periodontitis differently; Study I combined moderate to severe periodontitis, and 
Study II presented severe periodontitis only, indicating that severe periodontitis is a greater risk 
factor. 
Study II found a strong association between severe periodontitis and myocardial infarction 
in women (OR 3.72) and an even stronger association at ages below 65 years (OR 5.26). 
The	 corresponding	 associations	 in	men	were	 lower.	These	findings	 are	 novel	 since	 gender	
aspects in the relation of periodontitis and cardiovascular disease are sparely studied. Women 
experience myocardial infarction later in life, and because upper age limits are often utilized to 
avoid a multiplicity of concomitant disorders, women are less represented in studies.28,88,94 One 
study investigating both women and men found clinical attachment loss to be more associated 
with a myocardial infraction in women (OR 2.08) compared to men (OR 1.34), supporting the 
findings	in	Study II.58 In the Women’s Health Study, a large prospective cohort study, myocardial 
infarction events were more common in women with self-reported periodontitis.68 In Study II, 
the associated risk was more obvious in women (OR 3.72) than in men (OR 1.67), and was only 
present in women 65 years or younger. One explanation for a stronger association in women than 
in men might be due to gender differences in susceptibility to risk factors. Diabetes is known to 
affect men and women differently thereby increasing the risk for myocardial infarction more in 
women than in men.28,88,119 Perhaps this is also true for severe periodontitis, and needs further 
investigation. Surprisingly, there were no differences in smoking habits between cases and 
controls among women or among men in Study II. This rules out smoking as an explanatory 
reason for the association between severe periodontitis and myocardial infarction in Study 
II. Diabetes, on the other hand, was more common in all cases regardless of gender, and in 
all four Studies (Studies I−IV) compared with the controls. This indicates that diabetes is an 
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important risk factor to periodontitis and myocardial infarction and emphasizes that individuals 
with diabetes need special attention. A limitation in Study II was the low number of included 
women, and the gender-related results might thus be coincidental. As already discussed, the 
findings	that	severe	periodontitis	seems	to	be	a	stronger	risk	factor	at	younger	ages	in	women	
could	perhaps	reflect	a	susceptible	individual	with	a	hyper-inflammatory	response,	and	with	an	
increased risk of developing periodontitis and atherosclerosis. 
 
Invasive dental treatments, such as dental extraction and sub-gingival curettage, are routinely 
performed in dental practice. Study IV	 found	 no	 evidence	 for	 an	 increased	 risk	 of	 a	 first	
myocardial infarction after invasive dental procedures. Experimental clinical evidence 
linking invasive dental treatment and vascular dysfunction suggests a strong association 
within	the	first	seven	days	after	dental	treatment.131 Although this relationship is important, 
it has not been well studied, which is surprising. One reason could be that it is challenging 
to investigate such an association, as invasive dental procedures are common, and it would 
be	difficult	to	find	a	comparable	group	that	has	not	received	this	type	treatment.	The	study	
by Minassian et al. reported an increased risk of vascular events, myocardial infarction and 
stroke,	in	the	first	four	weeks	following	an	invasive	dental	procedure;	however,	no	association	
with myocardial infarction events was observable.139 Study IV, done during the same time 
period as the Minassian et al. study, used a 4-week follow-up period beginning the day after 
the dental procedure and a much larger study population, and found no clear association. 
More	recently,	Chen	et	al.	have	confirmed	the	result	of	Study IV.159
Study IV conclusions, along with the results of Studies I−III, send strong messages. Studies 
I−III emphasize a possible, slightly increased risk for individuals with severe periodontitis to 
experience	a	first	myocardial	infarction,	but	the	treatment	or	examination	itself, as Study IV 
indicates, does not elevate this risk. As these are common procedures in general dental clinics, 
this	finding	should	be	reassuring.		
METHODOLOGICAL CONSIDERATIONS  
Study designs
Observational studies are important study designs in medical research as experimental studies 
are not always are possible. At the start of this thesis, several designs for investigating the 
relation between periodontitis, invasive dental treatment, and myocardial infarction were 
discussed. Because periodontitis develops over several decades, a longitudinal cohort 
study	was	judged	to	be	difficult	as	it	would	be	not	only	extremely	time	consuming	but	also	
expensive. The ideal study design for providing evidence of a causal relation would have 
been a prospective randomized clinical trial, the best of all designs in the hierarchy of study 
designs.160 However, randomly recruiting individuals with periodontitis free of cardiovascular 
disease and then offering dental treatment to only some of them, over a long period of time, 
would have been unethical. The case-control design which was chosen for all four studies, is a 
type	of	observational	study	in	which	two	groups	of	outcome	are	identified;	in	contrast,	a	cohort	
study follows certain exposures over time and measures and compares risks of disease between 
different exposures. The major strengths of case-control studies are that they are relatively 
inexpensive compared with cohort studies and often have a more ethical design for studying 
diseases that develop over long time.
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Internal and external validity
Internal validity is an important consideration in epidemiological studies. It determines to 
what degree the measurement actually measures what it was intended to measure,161 and is 
an indication of the strength of the study method. A study with high internal validity has a 
low frequency of selection bias, measuring bias, and confounding. In Studies I and II, this 
was	considered	when	defining	exposure	and	periodontitis	and	throughout	the	radiographic	
analysis. Radiographic measurements of periodontist have previously been used with a high 
correlation162-166 and it provides blinded evaluations by calibrated examiners. The outcome, 
the myocardial infarction diagnosis, was set by a physician according to standardized 
international criteria on myocardial infarction that are used throughout Sweden and which 
were used in all four studies.144 
External validity is another important consideration; it helps determines the generalizability of 
the results to another population. To achieve high external validity, internal validity must also 
be high. By including cases and controls from 17 different hospitals across Sweden, resulting 
in a study population of 1610 well-examined participants, Studies I and II were able to achieve 
high internal and external validity. Studies III and IV included all individuals in Sweden who 
had	experienced	a	first	myocardial	infarction,	both	fatal	and	non-fatal,	between	2011	and	2013,	
together with matched controls. This makes generalizability reasonably high in high-income 
populations similar to the Swedish population, where cardiovascular disease prevention is 
widespread and general oral health, good. 
Bias   
Bias, a systematic tendency in data collection resulting in misleading results, is important to 
consider when designing studies.161 Selection bias can occur in the method used to recruit study 
participants, for example, if an enrolled individual has a different association to the exposure 
and outcome compared to those who were eligible to participate but declined. Even though this 
was taken into consideration in Studies I and II by matching the study population with a control 
group, participation in the case and control groups was voluntary and if possible to reach by 
telephone. If healthier controls with better oral status were included, a selection bias might 
have been introduced, since more patients with a severely compromised oral status might have 
declined participation.  
Measurement	bias	or	information	bias	is	a	misclassification	of	the	level	of	exposure	or	of	the	
outcome itself. To diminish the risk of introducing measurement bias in Studies I and II, the 
definition	of	 the	exposure	was	stated	before	 the	outcome,	 the	myocardial	 infarction,	which	
strengthens these measures. In addition, trained and blinded dentists examined all radiographs. 
However,	radiographs	as	a	measure	could	have	been	misclassified	as	they	can	be	a	historic	
picture	of	a	now	stabile	periodontitis,	with	no	ongoing	inflammatory	response;	stable	patients	
might	be	misclassified	as	having	active	periodontitis.	However,	considering	that	both	diseases	
develop over decades, the actual activity of the periodontitis at the time of examination was 
deemed less important. 
When	gathering	data	from	registers,	there	is	always	a	risk	of	introducing	misclassification	bias.	
This could be the case in Studies III and IV if an individual reported as having received dental 
treatment had an incorrect diagnosis. It could be claimed that using periodontal treatment as 
a proxy for the exposure periodontitis is less robust in Study III compared to Studies I and 
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II. However, it is unlikely that an individual receiving three or more advanced periodontal 
treatments annually in combination with surgery does not have periodontitis. In this setting, 
if	it	occurred,	it	would	appear	as	a	non-differential	misclassification	bias,	a	bias	toward	null.	
In	other	words,	the	misclassification	would	be	equal	in	both	groups,	leading	to	a	faded	result.	
The risk of selection bias being introduced in Studies III and IV would be likely if the individuals 
receiving dental treatment were healthier and had easier access to dental care, which would 
explain some of the lack of association. However, this is very speculative. In Study IV, it could 
be speculated that the lack of association in the group where an invasive dental treatment had 
been performed two days prior to the myocardial infarction was related to protopathic bias;167 
if true, this would suggest that in the days preceding the myocardial infarction, the cases were 
less likely to attend dental health appointments due to weakness or sickness related to the 
coming myocardial infarction. 
Confounding
Confounding	is	a	variable	that	influences	both	the	exposure	variable	and	the	outcome	variable,	
causing a false association; for instance, although the analysis may unveil an association 
between exposure and outcome, it may actually be due to a shared external factor associated 
with the two (Figure 8).161 For a variable to be categorized as a confounder, three criteria must 
be	fulfilled:	(i) It must be a risk factor external to the outcome variable, (ii) It must be associated 
with the exposure in the source population during the study, and (iii) It cannot be affected by 
the exposure or the outcome. Importantly, the confounder should not be an intermediate step in 
the causal pathway between exposure and outcome (Figure 8). Confounding can be managed 
in	 several	 ways,	 through	 randomization,	 restriction,	 stratification,	 regression	 analyses,	 and	
matching. 
To distribute the basic cofounding factors in Studies I and II	 −	 such	 as	 age,	 gender,	 and	
geographic	location	−	each	case	was	matched	with	one	control.	The	study	participants	were	
recruited from throughout Sweden, with the intention of including participants from the 
broadest possible spectrum of educational and socioeconomic conditions. To be able to control 
for relevant confounders in Studies I and II, variables such as family history of cardiovascular 
disease, smoking, diabetes, education, and marital status had to be accurately known for 
all participants. Cardiovascular risk factors such as hypertension, dyslipidemia, and known 
diabetes were treated similarly in both groups, which thereby limited their confounding. In 
Studies III and IV, the study population was also matched for age, gender, and geographic 
area, and information on possible confounders was obtained though register data. Information 
on one possible confounder, which probably would have had a strong impact on the results of 
Studies III and IV	−	smoking	−	was	not	retrieved.	To	manage	confounding	in	all	four	studies,	
relevant confounders were adjusted for in regression models. 
IMPLICATIONS AND FUTURE RESEARCH 
Dental practitioners strive to maintain oral health by treating and preventing oral disease. As 
populations are becoming more elderly globally and in Sweden, there is reason to believe 
that people will have more complex medical histories as well as more complex oral health 
demands. This highlights the need for improved dialogues between the treating physician and 
dental care, where dentists serve as an important link to the health care system. The results 
of this thesis suggest that severe periodontitis may be a risk factor for myocardial infarction 
in susceptible individuals and younger women and underlines the need for improving such 
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collaborations. Thus, it is vital that we truly verify the role and the breadth of oral disease and 
its effect on systemic conditions.
In the near future, the prospective follow-up of the PAROKRANK cohort may be able to 
provide some evidence. Hitherto, the association between periodontal and cardiovascular 
disease has mostly been explored in observational studies; thus mainly generating large 
numbers of hypotheses. One could question whether more research with such designs will 
provide any additional information. Instead, perhaps future research should focus on study 
designs	that	can	provide	definitive	information	on	causality	or	effective	prevention.
 
A randomized intervention study would be desirable, however, it is outside the realm of 
possibilities if it includes a control group that will not be offered existing evidence-based 
periodontal treatments. Another way to attack the problem would be to broaden our 
understanding	of	the	underlying	inflammatory	mechanisms	of	periodontitis.	Individuals	who	
are most susceptible to the disease could then be detected, and custom intervention programs 
could	be	designed	to	reduce	the	inflammatory	response.	This	could	be	important	since	the	
association between periodontitis and myocardial infarction appears to be gender related. In 
an	era	where	the	pharmaceutical	industry	is	developing	novel	anti-inflammatory	and	immune-
modulating therapies, this is of special interest. If such personalized intervention programs 
could be designed, and if light is then shed on the causal pathway, novel treatment strategies 
might be possible. A new research design that has become more common is the genome-wide 
association study, which is an observational study design where the genome-wide set of 
genetic variants in different individuals is tested to detect disease associated variants. As an 
example, an association between periodontitis and hypertension was recently shown by using 
periodontal-linked single nucleotide polymorphisms (SNPs) and hypertension phenotypes.168 
This study design may be a future tool for elucidating the association between periodontitis 
and myocardial infarction. 
  
Research	 in	 this	 field	will	 continue,	 but	 hopefully	 in	 a	 different	 direction,	 and	 the	 future	
will certainly provide us with clearer information and better answers. However, for dental 
practitioners and most patients, the main goal is still to treat oral diseases and to maintain a 
high level of oral health, because these are important in themselves. In addition, the present 
thesis can conclude that such measures will not harm, but will probably ameliorate, the 
cardiovascular risk in our patients. 
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CONCLUSIONS
Based on the four thesis studies, it can be concluded that:
I.	 Periodontitis	is	more	common	in	patients	surviving	a	first	myocardial	infarction	
compared	to	controls	and	increases	the	risk	of	experiencing	a	first	myocardial	
infarction. 
II.	 Severe	periodontitis	is	more	strongly	associated	with	a	first	myocardial	infarction	
in women compared to men, particularly in women aged 65 years and under.
III. When periodontal treatment is used as a surrogate marker, there is no evidence 
that	an	association	between	periodontitis	and	a	first	myocardial	infarction	has	any	
significance	in	the	general	Swedish	population.	
IV. Invasive dental treatment, including dental surgery and tooth extraction, is not 
associated	with	an	increased	risk	of	a	first	myocardial	infarction	in	the	general	
Swedish population.
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Appendix 1. Information on data source in Study III from: the National Inpatient Register, the 
Swedish Prescribed Drug Register and the Dental Health Register
Variables Codes
Comorbidities ICD-10 and ATC code
Diabetes overall E.10-E.14 or A10A or A10B
Diabetes type 1 E.10+ A10AB
Diabetes type 2 (E.10-E.14 or A10A or A10B) – (E.10+A10AB)
Diabetes treatment regardless of type of 
diabetes
Treatment insulin A10A
Treatment oral  A10B
Periodontal treatments within 3 years, prior 
to index event 
The Dental and Pharmaceutical Benefits Agency 
codes system (In Sweden)
No record of dental treatment No registered code
No periodontal treatment ≠ 311, 312, 341, 342, 343, 441, 442, 444
≥one non-advanced periodontal treatment (311, 312, 341) + 3043
≥one advanced periodontal treatment with or 
without periodontal surgery
(342, 343, 441, 442, 444) + 3043
Numbers of periodontal treatment per year, 
prior to index event
one advanced periodontal treatment without 
periodontal surgery
(342, 343, 441, 442, 444) + 3043
two advanced periodontal treatments without 
periodontal surgery
(342, 343, 441, 442, 444) + 3043
≥three advanced periodontal treatments and/
or ≥one periodontal surgeries
(342, 343, 441, 442, 444) + 3043
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Appendix 2. Information on data sources in Study IV from: the National Inpatient Register, the 
Swedish Prescribed Drug Register and the Dental Health Register
Variables Codes
Comorbidities ICD-10 and ATC code
Diabetes E.10-E.14 or A10A or A10B
Heart failure I50
Atrial fibrillation I48
Angina pectoris I20
Stroke I60–64 , G45, I63–64, I60–62
CVD drug treatment ATC code
Antihypertensive C09_CD, C09_AB, C08C, C03A_x
Statins C10AA
Low dose aspirin B01AC06_x
Beta blockers C07_x
Dental treatments 
The Dental and Pharmaceutical Benefits Agency 
codes system (In Sweden)
Sub-gingival scaling 342, 343
Surgery* 401-405
Implant surgery 421-436
Periodontal surgery 441, 442, 444
Apical surgery 541, 542
Dental examination 101-116
X-ray examination 121-128, 131-134
Temporary treatment 301-303
Caries treatment 322
Supra-gingival scaling/prophylaxis 311, 312, 341
Fillings 701-708
Root canal treatment 501-523
Fixed prosthodontics 801-815, 845-848
Removable prosthodontics 821-839
Temporomandibular disorder treatment 601-691
*Including extractions
